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Abstract 
 
 A persistent challenge in quantitatively modeling a biological system is that the system 
often involves many components and just as dizzying number of interactions among those 
components. To further complicate matters, the parameters that characterize those interactions 
and components, like the rates of chemical reactions and concentrations of molecules inside the 
cell, have evaded detection by the conventional experimental tools. How does one model a 
system whose crucial parameters are unknown? And even if we know all the parameters inside 
the cell, there is an increasing uneasiness among many researchers that just writing down an 
equation for every interaction and components of the system is not practical. Crucially, it is not 
clear that such an extensive many-parameter model would always enhance our understanding of 
the complex biological system. A phenomenological model that involves just a few essential, 
easily measurable parameters that capture the essence of the complex biological system may 
provide insights that a many-parameter, large scale model may not provide.  In this thesis, we 
describe our attempts at obtaining such a model for two complex biological systems: 1.) Cell 
growth as a result of glucose metabolism, and 2.) in vitro maintenance of the embryonic stem 
cell’s pluripotency by a complex transcriptional network. 
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1. Motivation 
“Which end is nearer to God, if I may use a religious metaphor, beauty and hope, or the 
fundamental laws? I do not think either end is nearer to God. To stand at either end, and to walk 
off that end of the pier only, hoping that out in that direction is the complete understanding, is a 
mistake. And to stand with evil and beauty and hope, or to stand with the fundamental laws, 
hoping that way to get a deep understanding of the whole world, with that aspect alone, is a 
mistake." 
Richard P. Feynman, "The Character of Physical Law". Chapter 5. (1965). 
 
Quantitatively modeling biological systems: A challenge  
 
 A persistent challenge in quantitatively modeling a biological system is that the system 
often involves many components and just as dizzying number of interactions among those 
components. To further complicate matters, the parameters that characterize those interactions 
and components, like the rates of chemical reactions and concentrations of molecules inside the 
cell, have evaded detection by conventional experimental tools. How does one model a system 
whose crucial parameters are unknown? And even if we know all the parameters inside the cell, 
there is an increasing uneasiness among many researchers that just writing down a differential 
equation for every interaction and components in the system is not practical. Crucially, it is not 
clear that such an extensive many-parameter model would always enhance our understanding of 
the complex biological system. But this is not to say that individual chemical reactions and the 
interaction between the components that make up the system are not important. Richard 
Feynman’s statement at the top of this page elegantly, and perhaps overly poetically, describes 
this tug of war between thoroughly modeling the individual interactions and modeling the 
collective behavior that emerges from a large number of those interactions without accounting 
for the individual interactions. Physicists know very well, particularly from their work in many-
body physics, that even a system with many particles in which the interaction between every pair 
of particles is identical, can be an intractable by modern analytical techniques. But inside a cell, 
the interactions among the particles are different, spanning different timescales, concentrations, 
and spatial extents. This is one of the main challenges in quantitatively modeling biological 
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systems. Moreover, just as only a few types of particle-particle interaction in a solid-state system 
can lead to fascinating collective behaviors, the much larger number of interaction types inside a 
living cell produces fascinating array of collective phenomena. In this thesis, we explore two 
such behaviors: 1.) Cell growth as a result of myriad interactions, and 2.) in vitro maintenance of 
the embryonic stem cell’s pluripotency by a complex transcriptional network. 
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Figure 2.1. Complex network of chemical reactions is responsible for cell growth on 
glucose. (Source: IUBMB-Sigma-Nicholson metabolic pathways chart). 
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2. Quantitative models of passive transporters and
metabolism: A brief overview
Chapter summary
This chapter provides a brief overview of simple mathematical models that are commonly
used for studying passive transporters of glucose. It also surveys some conventional ap-
proaches to modeling sugar metabolism in cells, a complex network that underlies our ex-
perimental study in chapter 3.
2.1. How cells obtain energy from glucose
Every living organism must make all of its components from resources it gathers from
the environment and use those components for survival and reproduction. To fuel these
processes, all living organisms must extract energy from their surroundings. Among the
different sources of energy, sugars play a central role in almost all organisms. Plants and
primitive bacteria extract energy out of the photons from the Sun and use it to generate
sugars for consumption - a process known as photosynthesis. Certain single-cell organisms
like E. coli uptake ready-made sugars from their surroundings. Among the sugars that
both single-celled and multicellular oganisms relie on, glucose is single-handedly the most
preferred and important sugar molecule. This is partly seen from the fact that most other
forms of simple sugar (monosaccharides) and complex sugar molecules (polysaccharides)
are converted to glucose first, and then the cell digests the resulting glucose. In addition,
organisms as diverse as yeast and humans can derive the other monosaccharides that are
necessary to form polysaccharides for furnishing various parts of the cell (glycan biosynthesis)
from glucose. Glucose is therefore a versatile molecule that is both a primary source of energy
and an important building block of cellular components.
A striking result of evolution is that many organisms, from yeast to humans, use a vast
network of very similar chemical reactions to extract energy for metabolizing a glucose
molecule. Glucose metabolism involves extracting energy from glucose and storing it into
the phosphates of Adenosine TriPhosphate (ATP). The cell uses ATP to transport the stored
energy and release it for usage by breaking the phosphate bonds when needed. But a lot
more happens than that once a glucose molecule enters the cell. The cell makes a diverse
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set of enzymes to process the numerous bi-products that result in the process of glucose
metabolism. As some of those bi-products are responsible for fueling other parts of cell such
as amino-acid and glycan biosyntheses, the number of enzymes involved in processing each
of the bi-products can be quite complicated. Indeed, the mind-boggling ”wiring diagram”
that shows just some of these chemical processes (Figure 2.1) gives a sense of how complex
these processes are. Cell growth results from the concerted efforts of these chemical reactions
(Figure 2.1) and many others not shown in this wiring diagram. Despite having identified
and studied most of the enzymes involved in these processes, it has been a long standing
challenge to build a widely applicable quantitative model that describes exactly how fast a
cell will divide as a result of these processes. We will explore some conventional models that
attempt to do so later in this chapter.
2.2. Glucose transporters
Transporters residing within the cell membrane are vehicles that move biomolecules,
including glucose, between the extracellular and intracellular environments. Given the pref-
erence for glucose, many organisms suppress production of transporters and cellular ma-
chineries designed for digesting alternative forms of sugar when the cell senses glucose in
its environment. There are three types of glucose transporters in nature. One of them is
a passive transporter. Passive transporters carry glucose across the cell membrane, moving
glucose from a region with higher concentration to a region with a lower concentration of glu-
cose. Passive transporters in the budding yeast are known as HeXose Transporters (HXT)
in the budding yeast and GLUcose Transporter (GLUT) in mammalian cells, including in
some human cells. The other two types of transport are both energy-dependent. One of
them involves hydrolysis of ATP to use the liberated chemical energy for glucose transport,
while the other uses sodium ion gradient (SGLT in humans, which are found in epithelial
and kidney cells). In this thesis, we deal with only the passive transport.
2.3. Quantitative model of passive transporters
Passive transporters are governed by thermal fluctuations and transport biomolecules
from a region of high concentration to a region of low concentration (i.e. ”down the concen-
tration gradient”). The fact that such important transporters like GLUT2 (responsible for
glucose transport in pancreatic beta cells which in turn release appropriate levels of insulin)
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and HXTs (essential for uptake of glucose in S. Cerevisiae) are passive transporters that rely
on seemingly unreliable thermal noise for their operation, is at first, alarming. There are
at least two ways for a cell to cope with the fluctuations. One is that a single transporter
binds to a substrate (that its designed to transport) many times within a given unit of time,
thus the transporter has many chances to bring the substrate to the other side of the mem-
brane. A single GLUT transporter, for instance, experiences greater than 100,000 events
of glucose-binding per second on average. Not all these binding events lead to a successful
transport of the glucose to the other side of the membrane due to the inefficiency of the
bond that forms between the glucose and the transporter but by having a lot of attempts
in a given amount of time, the transporter can increase its chance of a successful transport
of the glucose molecule to the other side of the membrane. Another way to deal with the
fluctuations is by having a large number of transporters present on a cell membrane at a
given time. For example, there are typically some 100,000 or more HXTs covering the cell
membrane of a budding yeast. From modeling perspective, the large number of transporters
and the binding events allow us to avoid the Master equation approach. Instead, we can use
a set of deterministic equations to look at the mean-behavior of the passive transporters.
A common starting point for studying passive transporters is the model known variously
as the Alternating-conformer model, or the 3-state model which was first proposed by Wid-
das in 1950s. This model uses enzyme-substrate kinetics akin to Michaelis-Menten kinetics
and states that a transporter can cycle through any one of the three discrete states (Figure
2). This model has been viewed as the gold standard for fitting measured transport param-
eters of various passive transporters. While fitting parameters of the model to the specific
transporter is useful in illuminating the behavior of the particular transporter of interest,
one could seek a global understanding of passive transporters by asking questions such as
”What trends does one observe in the behavior of any passive transporter as one gradually
changes the substrate binding affinity of the transporter?”, instead of ”What is the glucose
binding affinity of HXT2?”. Its the questions of the former type that we are concerned with
in this section. After all, if there is a common belief that such a wide variety of passive
transporters seem to operate in the substrate-enzyme type kinetics that the 3-state model
describes, then this is an opportunity for us to study a biological mechanism in its generality,
independent of the organism.
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FIG. 2: Three-state model of a passive transporter
Here we implement the 3-state model of a generic passive transporter. The original
model of Widdas actually involves at least four states, each representing the possible state
of the transporter. They are: 1. transporter facing outward, waiting to capture glucose, 2.
transporter facing outward with the glucose in its grip, 3. transporter with glucose in its
grip and facing the cytoplasm, and 4. transporter facing inside the cytoplasm with glucose
released from its grip. Our 3-state simplification comes from focusing on a time scale that
is much longer than time needed for the conformational change from states 2 to 3 (and vice
versa) to occur. Thus, our three states are: 1. same as state 1 of the 4-state model, 2.
transporter with glucose in its grip (and can be facing either out or into the cytoplasm), and
3. same as state 4 of the 4-state model. The cost of this simplification is that we no longer
have information about the conformation of transporter with glucose in its grip.
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The analysis of this model proceeds through the standard detailed balance calculations.
Assuming that there is a source of glucose outside the cell and a sink (metabolism) inside
the cell maintaining a constant gradient of glucose across the membrane, the steady-state
flux of glucose can be obtained. The law of mass action puts a constraint on the activity
constants {k}. Our system is then described by:
 k31
k32[Gin]
 =
k12[Gout] + k31 + k13 k31 − k21
k32[Gin]− k12[Gout] k21 + k23 + k32[Gin]
x1
x2
 (2.1)
where xi and kij are the fraction of transporters in state i, and activity constant charac-
terizing transporter transition from state i to j respectively. [Gout] and [Gin] are extracellular
and intracellular glucose concentrations respectively.
The 2 x 2 matrix in Eqn. (2.1) is guaranteed to be invertible because it’s determinant
cannot be zero (due to activity constants and glucose concentrations always being non-
negative). The system can thus always be solved by computing its inverse regardless of the
values of {kij}.
I. Symmetric case
We first consider a symmetric passive transporter, one whose response to extracellular
concentration of glucose is exactly the same as that of intracelluar concentration (i.e. kij =
kji). We now have a reduction to three activity constants:
k12 = k32 ≡ k+ association (2.2a)
k23 = k21 ≡ k− dissociation (2.2b)
k13 = k31 ≡ k flipping (2.2c)
The steady-state glucose influx Rsym into the cell is (modulo proper units):
Rsym(α, β, k, [Gout], [Gin]) = k ∗ F (α, β, [Gout], [Gin]) (2.3a)
F (α, β, [Gout], [Gin]) =
α([Gout]− [Gin]))
α(β + 1)([Gout]− [Gin]) + α2[Gout][Gin] + 4β (2.3b)
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where α = k
+
k− and β =
k
k− . One reason for writing down the influx as such is that
it facilitates the revelation of scaling behavior. Suppose we have a glucose influx (i.e.
there’s more glucose outside the cell). Now, suppose we double all the affinities but keep
the concentration difference fixed. Then we’d expect the influx to double as well. This is
clearly seen in Eqn. (2.3) since α and β remain invariant (and thus F is invariant under the
doubling of afffinities), and only the k doubles. Thus, we see that in the symmetric model
Rsym(α, β, 2k, [Gout], [Gin]) = 2k ∗ F (α, β, [Gout], [Gin]) = 2influx(k+, k−, k, [Gout], [Gin])
(2.4)
This makes intuitive sense. It’s interesting to note that Rsym doesn’t just depend on
concentration difference, but rather on their averages (both geometric and arithmetic) as
well.
I. A. Symmetric : Michaelis-Menten
As expected, when either the extracellular or intracellular glucose concentration is zero,
the influx rate (2.3) reduces to Michaelis-Menten influx (here, we’ve set [Gin]=0):
Rsym(k
+, k−, k) = RM
[Gout]
[Gout] +KM
(2.5a)
RM =
kk−
k + k−
(2.5b)
KM =
4VM
k+
(2.5c)
Thus, increasing affinity for glucose (larger k+) accompanies decrease in KM , which is
in accordance with what we expect for a high affinity transporter. If the affinity is high,
the extracellular glucose doesn’t have to be so high to reach the maximum influx (i.e. KM
can be low), as is reflected by Eqn (2.5c). Also, it’s interesting to note that the maximum
flux of a symmetric transporter RM is independent of association affinity k
+. This can be
interpreted as follows: For a transporter to reach its full capability (transporting at a rate
near RM), a sufficiently large amount of extracellular glucose must be present (i.e. [Gout]
 KM). In this case, how much affinity the transporter has for glucose is irrelevant as not
finding enough glucose to bind is no longer the issue. What determines RM then is how
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fast the other functions of the transporter (release glucose it has caught (k−) then face back
out (k) to catch the next glucose molecules) are carried out. The faster they are (large k−
and k), the larger the RM . Of course, the caveat is that k
+ helps in setting how large is
“sufficiently large”.
I. B. Symmetric : Finite intracellular glucose concentration
Although by this point, the expressions already become burdensome to work with by
hand, we can still draw analytical conclusions and meaningful interpretations. Suppose we
now allow for a finite [Gin], then we seek the optimal affinity for glucose (optimal value
of k+), which is found to be
k+optimal = 2
√
kk−
[Gin][Gout]]
(2.6)
First, note of caution: above expression only holds for non-zero concentrations of glucose.
If either one of the two concentrations is zero, then there is no optimal k+ (we’d get Michaelis-
Menten in which it is always desirable to make k+ as large as possible).
We can interpret Eqn. (2.6) by noting that making k and k− larger, leads to increasing
the release of glucose by transporter and rate of conformational change (facing out to in,
and vice versa). But we saw from expressions (2.3a) and (2.3b) that Rsym scales linearly
with (k+, k−, k), which hints that to keep up with dissociation and flipping transitions, the
affinity should also increase. Another way to look at this is to note that larger k and k−
means that there will be more mistakes made by the transporter: releasing glucose back
out, spontaneously flipping to face the interior of cytoplasm before even grabbing glucose
from outside. The relationship between influx R and k+ is shown in Figure 3.
II. Asymmetric transport behavior
If the transporter is asymmetric, we can still draw some meaningful interpretations.
II. A. Asymmetric behavior: Michaelis-Menten
By assuming a zero intracellular glucose concentration, we once again obtain Michaelis-
Menten influx R:
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FIG. 3: Influx of glucose as a function of glucose binding affinity k+: x-axis is k+ and
y-axis is the influx of glucose R. The values used here are (modulo proper units) k=1, k−=1,
[Gout]=2, and [Gin]=1. The maximal influx occurs at k+ = 2
√
kk−
[Gin][Gout]]
.
R =
RM [Gout]
[Gout] +KM
(2.7a)
RM = (
1
k23
+
1
k31
)−1 (2.7b)
KM = RM(k21 + k23)(
1
k12k23
+
1
k32k21
) (2.7c)
Again, the interpretations given for the symmetric case can be used to explain why RM
is independent of transporter’s affinity for glucose association k+.
II. B. Advantage of asymmetry : Michaelis-Menten
Suppose we assume that the intracellular glucose concentration is zero, and that there’s
a steady state influx of glucose from outside the cell. For a given amount of glucose, is
it better for the transporter to be equipped with a symmetric response or an asymmetric
response? If asymmetry is better, how much asymmetry is beneficial? We are now ready to
answer these questions analytically.
The situation we envision here is described by Michaelis-Menten for asymmetric trans-
porter (Eqn(2.7)). We first introduce dimensionless variables α , β, and γ, where
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α ≡ k12
k32
association comparison:
out→ in
in→ out (2.8a)
β ≡ k31
k13
flipping comparison:
in→ out
out→ in (2.8b)
γ ≡ k23
k21
dissociation comparison:
out→ in
in→ out (2.8c)
Symmetric transporter corresponds to α = β = γ = 1. Second law of thermodynamics
imposes the constraint: αβγ = 1 regardless of symmetry. Equation (2.7c) can be written
with the aid of these variables as
KM =
RM
k12
(1 + γ)(α+
1
γ
) (2.9)
It may look like we haven’t done much. But in fact, we have written KM that facilitates
seeing why asymmetry is better. Given a fixed [Gout], one way to maximize influx is by
making RM large while making KM small. Notice that
RM = RM(k23, k31) (2.10a)
KM = KM(RM , k12, α, γ) (2.10b)
Here’s a proof that asymmetry results in larger influx of glucose: Suppose we assign
values k12, k23 and k31. Eqn. (2.10a) shows that this would fix RM and what remains to
be determined are α and γ. This corresponds to assigning specific values to the activity
constants for only the forward cycle in the 3-state model. Notice that whatever value we
assign to α (association comparison) and γ (dissociation comparison), we can always satisfy
the second law of thermodynamics by choosing β = 1
αγ
. Now, here comes the advantage of
writing KM as we did in Eqn (2.9); α and γ are factored out. In a symmetric transporter
(α = γ = 1), and hence
(1 + γ)(α+
1
γ
) = 4 Symmetric transporter (2.11)
It’s easy to see that KM is smaller (thus larger influx) for asymmetric transporter. In
particular, if we look at slightly asymmetric situation, in which α = 1 + δ and γ = 1 + δ
(where |δ|  1), we find
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(1 + γ)(α+
1
γ
) ≈ 4 + 2δ +O(δ2) < 4 (asymmetric transporter, δ < 0) (2.12)
For small (i.e. to O(δ)) and negative δ, the asymmetric transporter thus results in a
larger influx of glucose than the symmetric transporter, for the same amount of extracellular
glucose concentration. Notice that we have investigated only one type of asymmetry here,
namely that α = γ, but this was sufficient for our purpose. In general, there is no simple
way to determine what value of {k} would result in maximal RM . We’d have to resort to a
brute force to locate the optimal set {k}. But what we have just extracted analytically is
the fact that asymmetry always leads to a larger influx of glucose when [Gin] = 0 (and by
extension, [Gin] ≈ 0).
2.4. Design principles underlying passive transporters: Application to hexose
transporters (HXTs) in yeast
Passive transport is the only method of glucose transport in the budding yeast. The
budding yeast has eighteen hexose transporter (HXT) genes. But of these, only six of
the HXT genes are expressed and the remaining genes remain silent (they are often called
”pseudo genes”). The budding yeast uses a combination of these six Hxts (Hxt1-4, Hxt6,
Hxt7), varying the amount of each type of Hxt made depending on how much glucose is
available in its environment, to uptake glucose from its surrounding. Each of these Hxts
have values of Km and Vm that differ from each other, signifying their different uptake
capabilities.
In the previous section, we found that in a given environment (fixed [Gin] and [Gout]),
a passive transporter whose half-saturation value Km and maximal transport rate Vm with
the following relationship has the largest net uptake rate
Km,optimal = 2Vm
√
[Gin][Gout]
kk−
(2.13)
A transporter with a ”low” Km is referred to as a high-affinity transporter. For example,
those Hxts with high-affinity (Hxt2, Hxt6, Hxt7) are expressed highly in a ”low” glucose
environment ([glucose] ∼ 0.1%) whereas the low-affinity (those with larger Km: Hxt1, Hxt3,
Hxt4) are expressed highly in a glucose rich ([glucose] > 1%) environment. Although the
19
magnitude of Km does indeed measure the affinity of a transporter in this sense, it doesnt
tell the whole story in light of Eqn. (2.13). For instance, given two transporters with similar
Vm but with two distinct Km, its possible that the one with the larger Km (lower-affinity)
has a larger uptake rate than the other one if it satisfies expression (2.13). But traditionally,
the one that actually performs better would be known as having a lower affinity than the one
that actually performs more poorly. So relative magnitudes of Km of hexose transporters or
any other passive transporters, for that matter, dont tell the whole story.
As an example of above argument, consider the two hexose transporters Hxt4 and Hxt7 in
the budding yeast. They have similar values of Vm (Vm,Hxt4 = 12 nmol min
−1 mg−1, Vm,Hxt7
= 11.7 nmol min−1 mg−1). If we assume that both have about the same k− and k rates,
and that both are symmetric transporters, then the net influx difference between the two is
due to difference in their k+. Under this assumption, from Reifenbergers estimates (1997),
we estimate that k+Hxt4 is about 1/9 of k
+
Hxt7. While we cannot directly estimate any of the
rate constants, we can demonstrate some design principles underlying above argument by
assigning some values to the rate constants. Figures 4 and 5 show these ideas graphically.
Before studying asymmetric transporters, we briefly note that Eqn. (2.13) can be written
as
Km,optimal = 2
√
[Gin][Gout]
√
σ
1 + σ
, (2.14)
where σ = k / k−. σ is a measure of how much rate limiting the flipping transition is
compared to the substrate dissociation rate. As we’ll state later, it is possible to estimate
σ by measuring the iso-counter transport of radioisotope-tagged substrates. In fact, it will
turn out that σ is a natural parameter for use in understanding the behavior of asymmetric
transporters.
Symmetric transporters are known to exist in various cells. For example, certain trans-
porters in liver cells in humans are known to have the symmetric behavior and there is some
speculation that some of the primary Hxts may indeed be nearly symmetric.
A. Expression levels of HXTs: Symmetric model
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FIG. 4: By increasing the extracellular glucose concentration to [Gout] = 60 mM and keeping
intracellular glucose concentration fixed at [Gin] = 0.01 mM, Hxt4 now achieves a higher uptake
rate than Hxt7 despite its larger Km.
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FIG. 5: At [Gout] = 10 mM, [Gin] = 0.01 mM, k = k− = 1 (for both Hxt4 and Hxt7), and k+=1,
Hxt4 has lower influx than Hxt7.
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Fig. 6. Induc tion of HXT gene expression with the respective glucose
A. Maier et al. /FEMS Yeast
FIG. 6: Expression levels of the primary HXT genes in the budding yeast measured
by β-galactosidase assay (Taken from Maier et. al. (2002))
We can try to understand the expression levels of HXT1-7 using the symmetric model.
While there is no direct proof yet that any of the Hxts are symmetric transporters, we
can extract some simple design principles by assuming they are. First, note the following
expression of HXTs as a function of external glucose concentration (taken from Fig. 6 of
Maier et. al.(2002)):
The values of Km and Vm were obtained by two different methods (1. counter transport
using radioisotope tagging, and 2. Typical initial uptake measurement during the first five
seconds). Both have yielded values of Vm and Km that match each other closely. These
values are summarized in Table 1.
Hxt1 Hxt2 Hxt3 Hxt4 Hxt6 Hxt7
Km 107 2.9 29 6.2 0.9 1.3
Vm 50.9 15 18.5 12 11.4 11.7
TABLE I: Vm and Km of Hxts in budding yeast: Km is measured in mM. Vm is measured in nmol
min−1 mg−1.
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Four main observations can be made:
1. With the exception of Hxt1, the rest of the essential HXTs have a similar Vm.
2. We can roughly lump the Hxts into three sets {Hxt1}, {Hxt3}, and {Hxt2, Hxt6, HXT7}
according to the relative magnitudes of their Km.
3. Looking at the expression levels of HXTs (Figure 6), we see that those Hxts with relatively
low values of Km tend to be suppressed more rapidly as extracellular glucose increases than
those Hxts with larger values of Km. For example, HXT2, HXT4, and HXT7 are suppressed
more rapidly as [Gout] increases (all have Km ∼ 3). Expression of HXT3 is suppressed more
slowly than HXT2, HXT3, and HXT7 (Km ∼ 30). Finally, suppression of HXT1 is slowest
of them all as Gout increases.
4. Lower Kms are clustered together and there is a lone high-Km transporter (HXT1).
We now try to explain observations #2 - #4 using observation #1 and under the as-
sumption that Hxts are symmetric transporters. In this process, we can glimpse into how
the expression of family of symmetric transporters may be regulated.
Recall that the symmetric transporter is characterized by three rate constants, k, k− and
k+ (where we denote σ = k/k−). Lets assume that all the Hxts have about the same σ.
Then since Vm = k / (1+σ), this means that Hxt2-7 have about the same k value, according
to observation #1. This, in turn, means that k− is about the same for Hxt2-7. This would
mean that these Hxts differ mainly in their k+ (binding rate) values, which in turn directly
tunes their Km. We noted that among all the transporters with the same k, and k
−, there is
Km,optimal (for fixed values of [Gout] and [Gin]) that, if possessed by the transporter, results
in the maximum net influx among them all. First, note that
Km,optimal ∼
√
[Gin][Gout] (2.15)
Teusink et al. (2001) has observed that for a range of [Gout] from 10 mM to 250 mM,
its corresponding internal glucose concentration [Gin] ranges from 1.5 mM to 2.7 mM. The
HXT expression curves shown in Fig. 6 sweeps [Gout] in this range. Well keep [Gin] fixed
at 2 mM throughout the following analyses. Under these ranges of glucose levels, Eqn
(2.15) states that the square root behavior results in the Hxts with lower Km,optimal values
being more sensitive to changes in [Gout] than those Hxts with higher Km,optimal values. For
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FIG. 7: Fractional cost = net influx / maximum influx. For each curve, the values of [Gout]
and [Gin] are fixed and the symmetric binding rate k+ is varied. Unless otherwise specified, [Gin]
is 1.5 mM. Note the broadening of width as [Gout] / [Gin] increases (i.e., for Hxt, this is equivalent
to just increasing [Gout] since [Gin] remains constant around 2 mM). The values of [Gout] shown
here roughly correspond to the actual extracellular glucose concentrations the budding yeast is
subjected to in Fig. 6.
instance, a few mM of [Gout] fluctuation away from, say [Gout] = 10 mM results in Km,optimal
being varied a lot more than when the same few mM fluctuation is around [Gout] =100 mM.
Figure 7 shows this argument graphically. It shows that the fractional cost in net influx
when deviating from the Km,optimal at a given [Gout].
In Figure 7, the cost of deviating from Km,optimal is shown for various representative
values of [Gout]. For each Gout, the peak corresponds to the location of Km,optimal. Notice
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the overlap between [Gout] = 1mM and [Gout] =5 mM curves. If there was just a single
transporter, say optimized for [Gout]=1mM but not for [Gout]=5 mM, then in an environment
with [Gout]=5 mM, such a transporter would be able to uptake only about 60% of what it
is capable of transporting had there been a transporter optimized for [Gout]=5 mM as well.
Conversely, a similar remark can be made if the cell had a transporter optimized for [Gout]=5
mM but not for [Gout] = 1 mM
The square root dependence of Km,optimal on [Gout] means that the peak-to-peak distance
is closer for smaller [Gout] than for larger [Gout]. Also, as [Gout] increases, due to the relatively
stationary [Gin], the width of peaks broaden. This means that theres more overlap and
can thus explain why there are more Hxts with smaller Km than larger Km (Observation
#4). This also gives a plausible argument for the Hxts with lower Km being more rapidly
suppressed than those with higher Km as [Gout] increases.
While we do not know how symmetric the Hxts are, above argument at least gives an
insight into how to distribute symmetric transporters and some general principles behind
how much to repress the transporter in a range of external substrate concentrations.
B. Understanding design principles underlying passive transporters
Our approach to studying passive carriers is based on asking the following question:
”Given a passive transporter whose rate constants are measured, can we make sense of why
the rate constants have the magnitudes that they do, and not some other values?”. For
instance, if the glucose binding affinity of human erythrocyte is larger outside the cell than
in the cytosol, why must it be so?
From a designer’s perspective, one can ask what functions a given passive transporter
should be able to perform, and how to optimize it. The function is clear: shuttle biomolecules
of interest into and out of the cell. But here’s a dilemma: should a transporter optimize its
eﬄux or influx ability? Is there a cost associated with optimizing one of the two? That is,
to optimize its eﬄux, should its influx-ability be sacrificed to some extent?
Simultaneous increase in the eﬄux and influx of molecule is possible
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Is it good to have a ”balanced” transporter that is equipped with both respectable eﬄux
and influx abilities? To make this concrete, let’s consider the following: Any symmetric
transporter has same net influx as net eﬄux in the following sense; If there are 100 mM of
substrate X outside the cell and 1 mM of X in the cytosol, the net influx is the same as
the net eﬄux that would occur if there were 100 mM of X in the cytosol and 1 mM outside
the cell. But now, let’s tweak the parameters of the transporter (binding rates, dissociation
rates, and trans-membrane flipping rates). Is there a way to tweak the values in such a way
that we increase both the net influx and net eﬄux rates of the transporter? To do so, we
first propose to measure the ”relative fitness” of a transporter as follows:
Relative fitness = (Rinflux,asym −Rinflux,sym) + (Refflux,asym −Refflux,sym) (2.16)
”Relative fitness” is a measure of the overall performance of an asymmetric transporter
relative to a symmetric transporter. To be more specific, given two concentrations [Gmax]
and [Gmin] (where [Gmax] > [Gmin]) (”G” doesnt mean glucose. It means any substrate of
interest to the transporter), and values of k+ , k− , and k (binding rate, dissociation rate,
and flipping rate respectively), we take an asymmetric transporter with corresponding rates
k++δ+, k−+δ−, k+δ. We then compare the two using the metric (2.16). An example is
shown in Figure 8:
With this metric (2.16), we can now figure out if increasing both influx and eﬄux is
possible, starting out with a symmetric transporter.
It’s interesting that to increase both the net influx and eﬄux rates, the rate constants
should change in the same direction in both cases as shown in Figure 9. That is, if we
had observed that increasing the net influx requires shifting the outside binding affinity to
k+ + δ+ , then one may expect that increasing net eﬄux would require shifting the outside
binding affinity to k+ − δ+ . But this is observed not to be the case. We have thus showed
a rather non-intuitive result that increasing both the influx and eﬄux rates simultaneously
is possible in some situations.
There are known passive carriers that need to effectively flush out substrates at times
but also intake substrates at other times. For example, during periods of starvation, our
liver cells need switch to eﬄux mode and synthesize glucose from amino acids, fatty acids
and other small molecules, which are then expelled out to the blood stream. Our result is
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FIG. 8: Relative fitness (Eqn (2.16) normalized by Rsym. Only positive fitness is plotted
by suppressing negative fitness (represented by flat region). The bulge represents asymmetric
transporters that are more ’fit’ than the symmetric transporter.
relevant for such transporters.
2.5. Many-parameter model of glucose metabolism in yeast
An example of an exhaustive, many-parameter model for glucose metabolism in yeast
is known as the Metabolic Flux Analysis (MFA). Below, we outline some basic features of
MFA and a related modeling framework known as the Metabolic Control Analysis (MCA).
Given a complex biological network, one would like to know how changing one node
(enzyme, substrate, product, etc) in the network affects the other nodes that are either
directly or indirectly connected to it. In particular, since during growth, cell’s metabolic
networks maintain near steady-state levels of fluxes, we can ask
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FIG. 9: (a) Relative net influx ability; (b) Relative net eﬄux ability. The appearance of peaks in
the same region in (a) and (b) indicates increase in both influx and eﬄux abilities of the asymmetric
transporter compared to the symmetric transporter.
• What is the steady-state distribution of fluxes in the metabolic network? Is it unique? If
not, why does one set of distribution get expressed but not the other (silent phenotypes)?
• How does perturbation of a particular enzyme or metabolite from its steady-state value
affect other parts of the network?
The first question is answered by Metabolic Flux Analysis (MFA) while the latter is answered
by Metabolic Control Analysis (MCA).
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I. METABOLIC CONTROL ANALYSIS (MCA)
A good way to understand MCA is by working through a simple example. Below, we
study the simple metabolic chain and introduce the terminology used in MCA. We will
highlight the MCA terms in red.
A. Toy model: Linear metabolic chain
A linear metabolic chain is defined as:
S
V1−→ X1 V2−→ X2 V3−→ X3 V4−→ X4 V5−→ P (2.17)
Xi is a metabolite, S is an external substrate, and P is the final product of the
metabolism. Vi is the amount of metabolite Xj generated per unit time, and is called
the flux. MCA is a framework for quantifying how much change results in one part of
network (say X4) when you perturb another part of the network (say X1). In MCA, these
perturbations are always measured from the steady-state (in most cases, quasi-steady state)
of network. These perturbations are usually limited to first order. As such, let’s imagine
that there is a source that maintains constant pool of S and a sink that maintains a con-
stant pool of P in Eqn (2.17). Then everything in (2.17) is in steady-state with values (S0,
Xi,0). Now, we imagine perturbing the Xi’s and S about their steady-state value. Taylor
exapnding the flux balance equation for X1 about steady-state values (S0, X1,0) due to the
perturbation to first order, we obtain
d(X1 −X0)
dt
=
∂V1
∂S
∣∣∣
S0
(S − S0)− ∂V2
∂X1
∣∣∣
X1,0
(X1 −X1,0), (2.18)
and getting rid of units of concentration by normalizing leads to
d(X1 −X1,0)/X1,0
dt
=
V1,0
X1,0
S0
V1,0
∂V1
∂S
∣∣∣
S0
S − S0
S0
− V2,0
X1,0
X1,0
V2,0
∂V2
∂X1
∣∣∣
X1,0
X1 −X1,0
X1,0
. (2.19)
The terms highlighted with red in above equation are called elasticities and are defined
and denoted by
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εV1S ≡ ε1S ≡
S0
V1,0
∂V1
∂S
∣∣∣
S0
=
∂ln(V1)
∂ln(S)
∣∣∣
S0
εV2X1 ≡ ε21 ≡
X1,0
V2,0
∂V2
∂X1
∣∣∣
X1,0
=
∂ln(V2)
∂ln(X1)
∣∣∣
X1,0
We have just introduced one of three main coefficients in MCA:
• Elasticity coefficient εViXi−1 : Gives a local information about how much a flux Vi changes
due to perturbation of metabolite Xi−1 about its steady-state.
The main idea behind MCA is that using a set of these local elasticity coefficients, we
want to connect these various local coefficients (via connection theorems) to make a global
statement about the network and about rates and metabolites that are distantly connected
to the metabolite Xi−1 that’s being perturbed.
Getting back to the example, using the following Taylor expansion to first order:
ln(Xi/Xi,0) = ln(Xi,0/Xi,0) +
1
Xi,0
(Xi −Xi,0) +O((Xi −Xi,0)2), (2.20)
equation (2.19) is rewritten as
dy1
dt
=
V1,0
X1,0
ε1Sy0 −
V2,0
X1,0
ε21y1, (2.21)
where we defined
y1 ≡ ln(X1/X1,0)
y0 ≡ ln(S/S0).
As for the remaining metabolites, we have a similar expression for flux-balance:
dyi
dt
=
Vi,0
Xi,0
εii−1yi−1 −
Vi+1,0
Xi,0
εi+1i yi (2.22)
with yi ≡ ln(Xi/Xi,0).
At this point, we ask the following question: ”How do the values of Xi change if we
perturb the external substrate S flowing into the system?”. We can obtain an approximate
answer to this question by setting dyi/dt = 0 in Eqn. (2.22) and solving for yi for each i.
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This is an approximation since we’ve ignored the higher order terms. Recursively solving
for yi, yi−1, ... , y1, we get
yi =
ε1S
εi+1i
y0 (2.23)
Above introduces us to our second coefficient of MCA, the concentration control coeffi-
cient (also called response coefficient) CiS defined as
CiS ≡
dln(Xi/Xi,0)
dln(S/S0)
, (2.24)
which in our linear metabolic chain is just CiS =
ε1S
εi+1i
.
• concentration control coefficient CiS is a non-local dimensionless number that characterizes
fractional change in metabolite Xi due to fractional change in the external substrate S about
its equilibrium. This answers the question posed above.
One final coefficient of interest in MCA is a similarly defined control coefficient called
flux control coefficient with respect to a metabolic parameter p, denoted CVip :
CVip ≡
dln(Vi)
dln(p)
=
n∑
j=1
εijC
j
p + ε
i
p, (2.25)
which, in this linear metabolic model is simply
CViS = ε
1
S. (2.26)
This is a very simple result in this particular toy model. Physically, all these flux control
coefficients are equal (and in particular, equal to C1S) since in a linear model, the steady-state
fluxes through each of the enzymes must be equal.
If we know the elasticities and the flux distribution in the metabolic network, we can
calculate the control coefficients of any metabolic system.
II. METABOLIC FLUX ANALYSIS (MFA)
In MFA, we represent every reaction that is taking place in our system of interest using
a Stoichiometric matrix S). Stochiometric matrix S has integer entries, and transforms a
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flux vector v(containing the reaction rates) into a vector that contains the time derivatives
of the concentrations. In other words, we want to solve
d~x
dt
= S~v, (2.27)
in steady-state. To do so, MFA uses techniques from linear algebra (in particular Single-
Value-Decomposition (SVD)). You can imagine that S is typically a very large matrix (e.g.
541 x 609 is the size of S for a soil bacterium Geobacter sulfurreducens), thus it typically
admits many steady-state solutions vss to above equation. But by gathering all we know
about, say the E.coli metabolism (e.g. Number of H+ typically present in the cell (answer:
≈ 16), ratio of tRNAs to number of ribosomes (answer: about 10)) and so forth, dedicated
large-scale modeling softwares can put constraints in the solution space, excising many of the
vss that are mathematically correct, but are not biologically relevant. Sometimes, one is able
to excise away enough biologically irrelevant solutions, leaving us with very few possibilities.
From these, we can predict a set of fluxes that leads to optimal biological function (e.g.
growth rate (bio-mass production)). This is often done using linear programming.
Here, we stay modest and restrict ourselves to construction of low dimensional Stochio-
metric matrices.
Example. Consider a system with just the following three reactions:
CP
v1↔ PC,
C + P
v2↔ CP,
C + AP
v3↔ CP + A,
(7)
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and the corresponding stochiometric matrix is thus
v1 v2 v3
S =

0 0 1
0 −1 −1
0 −1 0
−1 1 1
0 0 −1
1 0 0

A
C
P
CP
AP
PC
(8)
where the rows correspond to the metabolites indicated and columns correspond to
reactions v1, v2, v3 respectively. Since the signs are taken care of in the stochiometric matrix
S, the flux vector v must have entries that are non-negative. As we’ll see, this leads to
convex analysis being useful for analyzing the steady-state solution space. Notice that above
S indeed leads to
d~x
dt
= S~v, (2.28)
where ~x = [ [A], [C], [P], [CP], [AP], [PC] ]T . The goal of MFA is to solve above equation
for steady-state, thus obtain a set of possible steady-state fluxes ~vss.

Supplementing the stoichiometric matrix is an elemental matrix E. This matrix gives us
the composition of all the chemical elements and compounds in a given network. Again, an
example clarifies this notion:
Example. The following reaction:
2H2 +O2 → 2H2O,
has the following elemental matrix:
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H2 O2 H2O
E =
 0 2 1
2 0 2
 O
H
(9)

Since no chemical element can be created or destroyed in any chemical reaction, the
following conservation law holds (matrix multiplication between E and the stoichiometric
matrix of the system S):
ES = 0 (2.29)
This is a trivial example but it’s precisely constraints of this sort (and there are many
others, many of which are specific to a particular system being modeled) that will limit the
solution space in steady-state. And if we have enough constraints to end up with a very
small set of solutions, we can even simulate or experiment with those solutions and obtain
the one that optimizes a biological function of interest such as growth rate.
2.6. A need for a phenomenological model of cell growth
In the previous section, we described two of the conventional quantitative models for de-
scribing the large-scale, complex network that forms glucose (and its bi-product) metabolism.
But if our question is, ”How fast does a yeast cell divide given a certain amount of glucose
in its envrionment?”, it seems that there should be a way to answer this question without
caring about each individual chemical reaction that goes on inside the cell to break down a
glucose molecule. One approach may be to identify a few ’rate limiting steps’ in the complex
network of reactions shown in Figure 2.1. This has been difficult as many of these pathways,
if suppressed, are compensated by other intact pathways to break down a glucose molecule.
In the next chapter, we provide a phenomenological model of yeast growth that does not
require identification of any rate limiting steps.
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Chapter summary 
 A central challenge in systems biology is describing how so many intracellular 
components work together to execute a biological function using a quantitative model that 
involves only a few essential parameters. By judiciously stripping away the complexity, such a 
model can highlight the key principles and provide deep insights that are either difficult to 
extract from or completely missed by large-scale (e.g. whole-genome) models. Providing a 
quantitative picture of microbial growth on nutrients, such as the growth of the budding yeast on 
the key carbohydrate glucose, is one of the oldest problems currently facing such a challenge. 
The work in this chapter tackles that challenge through quantitative growth experiments. 
  This chapter begins with simple growth experiments that show surprising features of 
budding yeast growth that go against predictions of many conventional growth models as well as 
some of our own intuitions. For instance, despite an increase in both the extracellular glucose 
level and cells’ glucose import rate, cells do not just grow faster – they can grow slower and 
even approach a growth arrest. We find that this is because the cell’s growth rate is determined 
by the convolution of two key mechanisms: glucose perception and import. Conventional growth 
models ignore the interplay between these two mechanisms. Experiments in this chapter lead us 
to an intuitive and quantitative model that demonstrates glucose perception and import are two 
separate modular components of cell growth that we can experimentally tune independently of 
each other. Because these two mechanisms trigger all the down-stream intracellular activities 
that are responsible for growth, our empirical model in fact incorporates the amalgamated effect 
of those vast intracellular activities into just two key terms that are easily measurable. 
 The work in this chapter shows that the approach commonly used in physics to extract 
the essence of a complex system can also be applied in tackling one of the oldest problems in 
biology.  
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3.1.  Introduction 
 In 1942 Jacques Monod introduced his microbial growth model1 that prompted 
quantitative studies of microbial metabolism2-13. This motivated a wealth of mathematical 
models describing the growth of budding yeast Saccharomyces cerevisiae on the key 
carbohydrate glucose14. These models mainly focus on the effect of glucose import on the 
growth rate. But in addition to importing glucose, yeast senses extracellular glucose through 
several glucose sensors. These two key events at the cell membrane – glucose sensing and import 
– then trigger many downstream intracellular molecular events (e.g. transcription, metabolic 
processes, post-transcriptional modifications) that collectively determine the growth rate15. Many 
conventional models overlook this collective effect by ignoring glucose sensing. Growth 
behaviors that are qualitatively very different from current models’ descriptions may arise if 
glucose sensing and import are properly taken into account. One approach to addressing this 
deficiency is constructing detailed many-parameter models that attempt to explicitly track each 
of the vast molecular events involved in the yeast’s glucose metabolism8,9. Such approach has 
provided detailed information on the flux of thousands of known metabolic reactions and new 
insights into yeast’s growth on glucose. However, such an approach also conflates the effects of 
glucose sensing and import because it is not yet known how each of the vast molecular events 
are altered when glucose import rate is varied independently of the level of extracellular glucose 
sensed by the cell. The enormous number of metabolites and reactions involved makes 
experimentally determining each molecular change due to glucose sensing and import 
challenging. Indeed, a persistent challenge in obtaining a quantitative understanding of microbial 
growth on nutrients has been identifying just the few parameters that are necessary for extracting 
the central features from this complex cellular process. A phenomenological model that retains 
just those essential parameters may provide new insights and central design principles16,17 
underlying microbial growth. Motivated by these considerations, we sought to decouple and 
measure the separate effects of glucose sensing and import on cell growth, then provide a concise 
phenomenological model that elucidates how the interaction between the two determines the 
growth rate. 
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3.2.  Dependence of growth rate on glucose concentration 
 To measure and separate out the effects of glucose perception and import on growth rate, 
we first decouple any control that glucose sensing has on glucose import. Such coupling 
primarily comes from the two glucose sensors (Snf3 & Rgt2)18 that drive the transcriptional 
regulation of the six primary hexose transporters (Hxt1-4, 6 & 7)19-23 which are responsible for 
glucose import (Figure 3.1). Our background strain lacks all the major and minor glucose 
transporter genes (hxt1-17Δ, agt1Δ, stl1Δ, gal2Δ)24, thus no sensors affect the transcription level 
of any transporter genes including the HXTs. We made five “single-HXT” strains by introducing 
into the background strain only one of the five primary HXT genes (excluding HXT7) under the 
control of the inducible promoter PTET07. Each of these strains contains just one type of HXT 
gene, and its expression level could be controlled by the inducer doxycycline independently of 
extracellular glucose (Figure 3.2). We measured the log-phase growth rate of the single-HXT 
strains in minimal media containing a range of different concentrations of doxycycline and 
glucose, whose concentrations were held constant during batch growth for each experiment. We 
found surprising behaviors in every single-HXT strain’s growth rate (Figures 3.3 and 3.4). Since 
glucose no longer regulates the transcription of the sole HXT gene in our strains in a complicated 
manner, one would expect that an increase in extracellular glucose concentration would lead to a 
simple increase in the single-HXT strain’s glucose uptake rate (when the doxycycline 
concentration is held constant). A typical conventional model14 predicts that the growth rate 
should thus simply rise as the glucose level increases. Yet, depending on the initial glucose level, 
a further increase in the glucose level either increases or decreases the “Hxt1-only” strain’s 
growth rate (Figure 3.3). This is also true for the growth rates of the “Hxt2-only” and “Hxt4-
only” strains. Furthermore, despite growing as well as other strains at low glucose levels, the 
“HXT3-only” and “HXT6-only” strains even approach growth arrest for glucose level higher than 
0.02% (Figure 3.3). Thus, we observed no systematic relationship between glucose level and 
growth rate. It is noteworthy that the wild-type strain, unlike these single-HXTs, simply grows 
faster when more glucose is present (Figure 3.3), a behavior we will consider more closely later. 
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Figure 3.1. :  Expression levels of HXT genes in wild-type strain (CEN.PK2-1C) measured 
using YFP reporters (used “Wild-type PHXTn:YFP” strains; see “strain list”).  As the 
extracellular glucose concentration varies, the expression level of each HXT gene in the wild-
type strain changes. Two of the glucose sensors, Snf3 and Rgt2, initiate the signal transduction 
that results in these expression patterns. This result was originally reported in a previous work3. 
We have reproduced it here for the sake of completeness. Error bars, s.e.m.; n=3. 
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Figure 3.2. :  Inducibility of PTET07 inferred from YFP fluorescence as a function of 
doxycycline concentration in the HY4DCal5 strain. HY4DCal5 and the single-HXT strains 
were all constructed using the same background strain HY4D1. Hence we can infer the 
inducibility of the promoter PTET07 in the single-HXT strains from this induction curve measured 
in the HY4DCal5 strain. The fluorescence data shown here were obtained while the cells were 
in log-phase growth in a standard synthetic media with 2% maltose and the indicated 
doxycycline concentration. The colored vertical dashed lines indicate the concentrations of 
doxycyline used in subsequent figures for characterizing the single-HXT strains. Error bars, 
s.e.m.; n=3. 
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 Figure 3.3. : Growth rates of “single-HXT“ strains do not show any systematic trend with 
respect to glucose concentration. Log-phase growth rates of the wild-type strain (CEN.PK2-
1C) and five single-HXT strains at varying [glucose] but constant [doxycycline] (0 µg/ml for wild-
type and 2.5 µg/ml for single-HXT strains) are shown. The shape of each single-HXT strain’s 
growth-rate curve is maintained over a wide range of doxycycline concentrations (Figure 3.4). 
The growth-rate curves of the “single-HXT” strains display stark differences from the wild-type’s 
curve: single-HXT strains’ growth rates can substantially decrease, and some strains even 
approach growth arrest, despite a monotonic increase in [glucose]. Error bars, s.e.m.; n=3. 
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Figure 3.4. : (See next page for figure caption). 
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Figure 3.4. : Growth rate of single-HXT strains in various combinations of glucose and 
doxycycline concentrations. We measured the log-phase growth rate of the single-HXT 
strains in synthetic growth media containing doxycyline and glucose. These concentrations 
remained constant during each batch growth experiment. Each color corresponds to a particular 
value of doxycycline concentration as indicated in Figure 3.2. A curve of a given color shows 
how the growth rate changes as a function of the glucose concentration (at fixed doxycycline 
concentration). None of these strains’ growth rates increase monotonically with an increase in 
the glucose level, unlike the parental wild-type strain (Figure 3.3). Depending on the initial 
glucose level, a further increase in the glucose level either increases or decreases the single-
HXT strain’s growth rate. Error bars, s.e.m.; n=3. 
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 3.3.  Dependence of growth rate on glucose uptake rate 
 Using our doxycycline inducible expression system, we were able to show that for every 
single-HXT strain at fixed doxycycline level, the glucose uptake rate increased as the glucose 
level increased (Figure 3.5). To measure glucose uptake rates, we fused yEGFP to the inducible 
HXT gene in each of the single-HXT strains (Figure 3.6). Measuring the average single-cell 
fluorescence in these strains gave us the relative number of Hxt proteins synthesized in these 
cells (Figure 3.7). Using the known Michaelis-Menten parameters of the Hxts25,26, we calculated 
the cell’s total glucose uptake rate. We also directly measured the cell’s glucose uptake rate. The 
directly measured and calculated uptake rates were in good agreement (Figure 3.8): glucose 
uptake rate increased as the glucose concentration increased (at constant doxycycline 
concentration) (Figures 3.5 and 3.9). Hence despite a monotonic increase in both glucose uptake 
rate and extracellular glucose level, single-HXT strains at fixed doxycycline concentration can 
grow significantly faster, or slower, or even approach growth arrest as seen earlier (Figure 3.3), 
effects that no conventional growth model can either quantitatively or qualitatively describe. 
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 Figure 3.5. : A rise in [glucose] yields an increase in the uptake rate, but cells do not 
necessarily grow faster. To both measure and calculate glucose uptake rates, yEGFP was 
fused to the HXT gene in each “single-HXT” strain. These fluorescent single-HXT strains have 
the same growth-rate features as their non-fluorescent counterparts shown in Fig. 3.3 (Figure 
3.6). The measured glucose uptake rates per cell for just three of these fluorescent single-HXT 
strains at [doxycycline] = 2.5 µg/ml are shown here. These fluorescent single-HXT strains’ 
glucose uptake rates monotonically increase as [glucose] increases, despite the non-systematic 
behavior of their growth rates reflected in Fig. 3.3. Hence, a cell can grow faster, or slower, or 
approach growth arrest despite an increase in both its glucose uptake rate and [glucose]. Error 
bars, s.e.m.; n=3. 
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Figure 3.6 : (See next page for figure caption). 
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Figure 3.6. :  Growth rate of fluorescent single-HXT strains (yEGFP fused to a HXT gene 
in each single-HXT strain) in various combinations of glucose and doxycycline 
concentrations. Each color corresponds to a particular value of doxycycline concentration as 
indicated in Figure 3.2 (purple represents [doxycycline] = 0.25 µg/ml). Fusing yEGFP to a HXT 
gene results in functional fluorescent single-HXT strains whose growth rates show the same key 
features that their non-fluorescent counterparts exhibit (Fig. 3.4). These fluorescent strains thus 
exhibit the same apparent non-systematic behavior in their growth rates as their non-fluorescent 
counterparts. Error bars, s.e.m.; n=3. 
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Figure 3.7 : (See next page for figure caption). 
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Figure 3.7. : Average, steady-state, single-cell yEGFP levels in the fluorescent single-HXT 
strains growing in various combinations of glucose and doxycycline concentrations. In 
the single-HXT strains with the yEGFP fused to the HXT gene, the relative number of Hxt 
proteins per cell was inferred from the average single-cell fluorescence measured using flow 
cytometer (See methods). Each color corresponds to a particular value of doxycycline 
concentration as indicated in Fig. 3.2 (purple represents [doxycycline] = 0.25 µg/ml). The fact 
that single-cell fluorescence value changes as the glucose level changes (at constant 
doxycycline level), indicates an existence of post-transcriptional regulations of the Hxts. Indeed, 
previous works have revealed some glucose dependent post-transcriptional regulations of Hxts 
(e.g., endocytosis of Hxt6 & Hxt7 at high glucose levels)4 and other metabolic genes2,5. We took 
into account the effect that such regulation has on glucose uptake by directly measuring the 
uptake rates. The cell’s glucose uptake rate is determined by the combination of two parameters 
– the amount of Hxt protein in the cell and the extracellular glucose concentration. By measuring 
the glucose uptake rates, we found that all the single-HXT strains’ glucose uptake rates 
monotonically increase when the glucose concentration increases (at fixed doxycycline level; 
Figures 3.5 and 3.9). This is because even though the number of Hxt protein in a cell may 
decrease when the glucose level rises  (at fixed doxycycline level), this decrease is feeble: it is 
more than compensated by the accompanying increase in the glucose level, resulting in net 
increase in glucose uptake rate. This is confirmed by both our measured and calculated glucose 
uptake rates (Figures 3.8 and 3.9). Error bars, s.e.m.; n=3. 
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Figure 3.8. :  Comparison of measured glucose uptake rate (GUR) with calculated GUR of 
the fluorescent single-HXT strains. The measured and calculated values of glucose uptake 
rate of all the fluorescent “single-HXT” strains are plotted together here. GURs are reported in 
normalized units to show that relative changes in both the measured and calculated GURs are 
in good agreement with each other. Error bars, s.e.m.; n=3. 
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Figure 3.9. :  Measured glucose uptake rates (GURs) of fluorescent single-HXT strains 
growing in various combinations of glucose and doxycycline concentrations. Each color 
corresponds to a particular doxycycline concentration as indicated in Figure 3.2 (purple 
represents [doxycycline] = 0.25 µg/ml).  For “Hxt3-only” and “Hxt6-only” strains, only the GURs 
at [doxycycline] = 2.5 mg/ml are shown here for clarity. Since these two strains transiently 
approach near growth arrest for [glucose] > 0.02%, their GURs could not be measured using 
our method for [glucose] > 0.02%. Instead, we calculated their GURs as they transiently 
approached near growth arrest based on their yEGFP fluorescence (Figure 3.7).  Close 
agreement between the measured and calculated GURs (Figure 3.8) gives us confidence in 
these calculated GURs. Error bars, s.e.m.; n=3. 
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3.4.  Phenomenological model of growth 
Plotting all five single-HXT strains’ growth rates and uptake rates together resulted in a wide 
scatter of data points, where each data point is specified by two coordinates: uptake rate and 
growth rate (Figure 3.10). This plot reveals that uptake rate alone cannot specify the cell’s 
growth rate. Specifying the glucose concentration by color-coding these data points (i.e., each 
data point now has three coordinates: (uptake rate, extracellular glucose concentration, growth 
rate)) causes a striking pattern to emerge (Figure 3.11). This analysis reveals that growth rate µ is 
determined by two independent variables: the glucose uptake rate r, and the extracellular glucose 
concentration g. Our full experimental data set of all five single-HXT strains over a wide range of 
glucose and doxycycline concentrations are described by a single equation     
        [3.1] 
where µc and rc are constants specifying the point of convergence of the log-linear lines (Figure 
3.11), and the function P(g) describes the slope of the log-linear correlation between µ and r for 
each value of g. This equation does not depend on which Hxt the cell uses for glucose uptake. 
This slope P(g) increases with increasing g, and in turn tends to decrease growth rate (when r < 
rc). P(g) quantifies the dramatic effect that the extracellular glucose has on growth rate 
independently of glucose import – the effect of glucose perception. Qualitatively, Eqn. [3.1] 
states that an increase in the extracellular glucose concentration may cause two counteracting 
effects: an increased glucose uptake rate r (which tends to increase growth rate), and an 
increased perception of extracellular glucose (which tends to decrease growth rate). The net 
result on growth rate (i.e., whether it rises or falls) is decided by the competition between these 
opposing effects of glucose perception and uptake. Which one of the two effects dominates 
depends on the actual values of g and r, in particular on the product P(g)ln(r/rc) quantifying the 
interaction between glucose perception and import (Supplementary text). 
 The “growth landscape” in Figure 3.12, described by Eqn. [3.1], shows the full set of 
growth rates possible for a wide range of g and r. Because Eqn. [3.1] does not distinguish 
between the type and number of Hxts cells use for glucose import, it is applicable to cells with 
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any number of HXT genes, including the wild-type, as long as the cells achieve the uptake rate 
within the range we probed. The shape of this landscape allows for the unusual growth-rate 
behaviors observed, including the convex shaped growth rate of the “Hxt1-only” strain (orange 
path, Figure 3.12), the “Hxt6-only” strain’s path towards growth arrest (red path, Figure 3.12) 
and the wild-type’s hyperbolic growth rate (blue path, Figure 3.12). The wild-type strain is near 
the peak of this growth landscape yet its uptake rate is not much higher than those achieved by 
some single-HXT strains. The growth landscape shows that some values of (g, r) cannot sustain 
growth (µ = 0). Indeed, for every g, there is a minimum uptake rate a cell needs to have in order 
for it to have any chance of growing in that particular glucose environment (Figure 3.13).  
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Figure 3.10. : Result of plotting the growth rate and the measured glucose uptake rate 
(GUR) of all the fluorescent single-HXT strains together. This shows that for a particular 
value of glucose uptake rate, multiple values of growth rates are possible. This means that 
glucose uptake rate alone cannot specify the cell’s growth rate. But additionally coloring these 
data points according to the value of the extracellular glucose concentration leads to a striking 
pattern observed in Figure 3.11.  
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Figure 3.11.:  Emergence of a concise growth model incorporating cell’s perception and 
uptake rate of glucose. Plotting together all the measured growth rates and glucose uptake 
rates of the fluorescent single-HXT strains (Figure 3.10) then color-coding by extracellular 
glucose level reveals this striking pattern. This plot shows that extracellular glucose 
concentration g and glucose uptake rate r are two independent variables. Growth rate is 
concisely described by the fit function µ(r, g). P(g) is the slope of the log-linear correlation 
between growth rate and uptake rate for each g; we obtain P(g) by fitting. µc and rc are 
constants specifying the point of convergence of the log-linear lines (µc = 0.44 hr-1 ,rc = 1.4x107 
molecules/s). Error bars, s.e.m.; n=3.  
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Figure 3.12. : The Growth landscape formed by perception and import of glucose in 
yeast. Full “growth landscape” of budding yeast: Three dimensional plot of the function µ(r, g). 
The “growth trajectories” followed by the parental wild-type (blue path, near the peak of this 
landscape), and fluorescent “Hxt1-only” and “Hxt6-only” strains (orange and red paths 
respectively) are shown. Colored arrows indicate the direction the cell travels on each path as g 
increases. The arrows along the two axes (along “[glucose]” and “Glucose uptake rate”) point in 
the direction of increase. 
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Figure 3.13.: Minimum glucose uptake rate rmin required for growth as a function of 
extracellular glucose g. 
€ 
rmin = rc exp −
µc
P(g)
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟  is the function describing these two curves, with 
P(g), rc, and µc fitted for a cell with the sensors (black line) and without the sensors (red line) 
(derived from Eqn [3.1]; see Figure 3.20 for “without sensor” strains). This shows that cells 
require a larger glucose uptake just to avoid growth arrest as more extracellular glucose is 
perceived. 
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3.5.  Manipulation of glucose perception by sensors 
 
 Whereas the glucose uptake rate depends on the Hxts, glucose perception – captured by 
P(g) – should depend on mechanisms the cell uses to measure the level of extracellular glucose. 
Snf3 and Rgt2 are two glucose sensors primarily known for regulating transcription of both 
major and minor glucose transporter genes18, 27 (HXTs, GAL2, STL1, AGT1). Since such 
regulation is disabled in our single-HXT strains, we could manipulate P(g) by knocking out these 
two glucose sensors without affecting the uptake rate r. We constructed a panel of single-HXT 
strains with these two sensors deleted (Figure 3.14). The relationship between growth rates and 
extracellular glucose concentration in these “sensorless” strains is strikingly different from that 
in strains with the two sensors intact (Figures 3.15 and 3.16). Growth rates now generally 
increase as the glucose level increases (at constant doxycycline level). Also, without the sensors 
the “Hxt3-only” and “Hxt6-only” strains no longer approach growth arrest as the glucose level 
increases. Because we deleted all minor glucose transporter genes and removed the glucose’s 
control of the sole transporter expression in our single-HXT strains, changes in uptake rate were 
not the reason for the growth rescues we observed. For every combination of glucose and 
doxycycline concentrations, the uptake rate of the sensorless strains was nearly identical to the 
uptake rate of their sensor-containing counterparts (Figures 3.17 and 3.18).  
In the sensorless strains, growth rate again explicitly depends on glucose concentration 
but with much reduced sensitivity (Figures 3.19 and 3.20). When Snf3 and Rgt2 are absent, a cell 
in 4% glucose acts as if it were in 0.06% glucose with intact sensors. Since the uptake rate 
remains virtually unchanged in the single-HXT strains when SNF3 and RGT2 are deleted, this 
reduced-sensitivity effect is due to a change in the perception function P(g), not uptake rate r 
(Figure 3.20). The remaining dependence of the cell’s growth rate on the glucose concentration 
even after Snf3 and Rgt2 have been deleted suggests that other sensors may contribute to the 
effect embodied in P(g)28,29. Nonetheless, our experiments show that Snf3 and Rgt2 are the key 
determinants of P(g) (as quantified in Figure 3.20). 
The behavior depicted by Eqn. [3.1] should apply to the wild-type strain as well, as long 
as it achieves an uptake rate within the range probed with the single-HXT strains used to 
construct our growth landscape. We measured the wild-type’s uptake rate and found that it was 
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below the critical uptake rate rc for glucose concentrations smaller than 0.02% (Figures 3.11 and 
3.24). For higher [glucose], the uptake rate exceeds rc. When the wild-type cell’s uptake rate is 
below rc, its growth rate fits with the trend revealed in Figure 3.11. For higher glucose 
concentration, the effect of perception on the wild-type’s growth rate disappears (Figure 3.11). 
One possible explanation is that as long as the glucose concentration is not too low, the wild-type 
escapes the seemingly detrimental effect of perception on growth rate by making enough hexose 
transporters to go beyond rc. But for lower glucose level where its uptake is less than rc, it 
properly tunes the interaction between glucose perception and uptake (quantified by the product 
P(g)ln(r/rc)) such that its growth rate will increase when the cell perceives more extracellular 
glucose. Such tuning suggests that the transcriptional regulation of the HXT genes by Snf3 and 
Rgt2 is organized such that the wild-type always climbs uphill in the growth landscape (Figure 
3.12) as it perceives an increase in the extracellular glucose concentration. 
59
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14.: Comparing the inducibility of PTET07 in HY4DCal5 (black line, with intact 
SNF3 and RGT2 genes) and in HY5FCal2 (red line, snf3Δ  rgt2Δ). Single-cell fluorescence 
was measured using flow cytometer while HY4DCal5 and HY5FCal2 strains were in log-phase 
growth in standard synthetic media with 2% maltose and the indicated concentration of 
doxycycline. The colored vertical dashed lines indicate the concentrations of doxycyline used for 
characterizations of the “sensor-less” single-HXT strains (snf3Δ rgt2Δ) in subsequent 
supplementary figures. This plot shows that knocking out the two sensors makes only minor 
changes to the transcriptional activity of the promoter PTET07. Error bars, s.e.m.; n=3. 
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 Figure 3.15. : Manipulation of the cell’s perception of extracellular glucose yields 
significant growth-rate changes. Growth rates of single-HXT strains lacking two glucose 
sensors (snf3Δrgt2Δ, bold lines) along with their counterparts with intact sensors (dotted lines) 
are shown for [doxycycline] = 5 µg/ml. Error bars, s.e.m.; n=3.   
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 Figure 3.16. : Growth  rates of fluorescent 
 sensor-less single-HXT strains (snf3Δ  
 rgt2Δ) in various combinations of glucose 
 and doxycycline concentrations. Each 
 color corresponds to a particular value of 
 [doxycycline] indicated in Figure 3.14 (purple 
 represents [doxycycline] = 0.25 µg/ml).  
 These strains’ growth rates behave in a 
 starkly different manner from their 
 sensor-intact counterparts (compare with 
 Figure 3.6). “Hxt3-only” and “Hxt6-only” 
 strains no longer approach near growth 
 arrest when the two sensors are absent. 
 Error, s.e.m. n=3. 
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 Figure 3.17. : Knocking out the two glucose sensors leaves the cell’s glucose uptake rate 
virtually unperturbed. Just the “Hxt1-only” and “Hxt2-only” strains are shown here for simplicity 
(Figures 3.9 and 3.18 for others). Each data point represents a particular combination of 
glucose and doxycycline concentrations. Error bars, s.e.m.; n=3.  
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 Figure 3.18.:  Measured  glucose uptake 
 rates of sensor-less fluorescent single-HXT 
 strains (snf3Δ  rgt2Δ) in various
 combinations of  glucose and  doxycycline 
 concentrations. Each color corresponds to a 
 particular value of doxycycline concentration 
 indicated in Figure 3.14 (purple represents 
 [doxycycline] = 0.25 µg/ml). Knocking out the 
 two glucose sensors hardly perturbs the 
 glucose uptake rates of the single-HXT strains 
 (compare with Fig. 3.9). However, the 
 sensorless single-HXT strains’ growth rates are 
 qualitatively very different from those of their 
 sensor-intact counterparts (can be seen by 
 comparing Figures 3.16 and 3.6). This is due to 
 the diminished sensing ability of the sensorless 
 strains, as indicated by the significant decrease 
 in P([glucose]) (Figure 3.19). Having the 
sensors knocked out impairs the cell’s ability to perceive how much extracellular glucose is 
surrounding the cell.  In particular, the cell acts as if there is less glucose than there actually is 
(decrease in P([glucose])). Error bars, s.e.m.; n=3. 
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 Figure 3.19. : Phenomenological model of yeast growth, in the absence of two primary 
glucose sensors. By yEGFP fusion, fluorescent sensor-less single-HXT strains were 
constructed for comparison with their sensor-intact counterparts. The features of growth rates 
seen in Fig. 3.15 were preserved after this fusion (Figure 3.16). Growth rates and glucose 
uptake rates of these strains were measured (Figures 3.18 and 3.21-23). For comparison, data 
for the sensor-intact single-HXT strains (from Fig. 3a) are shown in grey ( c=0.40 hr-1,
c=1.4x107 molecules/s). Error bars, s.e.m.; n=3.  
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Figure 3.20.: Sensitivity to glucose is reduced in the absence of the two primary glucose 
sensors Snf3 and Rgt2. The sensitivity function P(g), calculated from fitting the data in Figures 
3.10 and 3.19 is shown for strains with intact sensors (black) and snf3Δrgt2Δ strains (red). Error 
bars indicate 95% confidence interval in these fits.  
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 Figure 3.21. :  Average single-cell, steady-
 state yEGFP fluorescence in the sensor-
 less single-HXT strains (snf3Δ , rgt2Δ) 
 in various combinations of glucose  and 
 doxycycline concentrations.  Each color 
 corresponds to a particular value of 
 doxycycline concentration indicated in   
 Fig. 3.14 (purple represents [doxycycline] = 
 0.25 µg/ml). The relative number of Hxt 
 proteins per cell was inferred from the 
 average single-cell fluorescence measured 
 using flow cytometer (See methods). Post-
 transcriptional regulations of Hxts are 
 observed in these “sensor-less” strains, just 
 as we observed such regulations in the 
 “single-HXT” strains with the sensors (See 
 Fig. 3.7). We took into account the effect of 
these regulations on the glucose uptake by directly measuring the glucose uptake rates. As in 
the sensor-intact single-HXT strains (Fig. 3.7), our measured glucose uptake rates of all the 
single-HXT strains monotonically increased as the glucose level increased (Fig. 3.18). The 
reason for this is identical to the one given in the figure caption for Fig. 3.7. Error bars, s.e.m.; 
n=3. 
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Figure 3.22.:  Comparison of measured glucose uptake rate (GUR) and calculated GUR of 
the sensor-less fluorescent single-HXT strains (snf3Δrgt2Δ). The measured and calculated 
values of glucose uptake rates of all the fluorescent single-HXT strains without the two glucose 
sensors (snf3Δ rgt2Δ) are compared here. GURs are reported in normalized units to show that 
the relative changes in both the measured and calculated GURs are in good agreement with 
each other. Error bars, s.e.m.; n=3. 
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Figure 3.23. : (See next page for figure caption). 
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Figure 3.23.:  Result of plotting the growth rate and the measured glucose uptake rate 
(GUR) of all the sensorless fluorescent single-HXT strains together. a. The color scheme 
represents the particular single-HXT strain (without SNF3 and RGT2) to which the data points 
belong. The overlap of data points belonging to different single-HXT strains but at the same 
GUR and glucose concentration, along with the pattern emerged in Figure 3.19, together 
demonstrate that only the value of GUR but not which Hxt was responsible for the glucose 
import, is a factor in determining the growth rate. b. Obtained by removing the colors from the 
data points shown in (a). This shows that for a particular value of glucose uptake rate, multiple 
growth rates are possible. This means that glucose uptake rate alone cannot specify the growth 
rate. But additionally coloring these data points according to the value of the extracellular 
glucose concentration leads to a striking pattern observed in Figure 3.19. 
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Figure 3.24.:  Average single-cell fluorescence in the ‘wild-type’ strain (CEN.PK2-1C) with 
yEGFP fused to each HXT gene. The relative number of each Hxt protein present in the wild-
type strain was inferred from these fluorescence levels. As in the single-HXT strains, the wild-
type’s glucose uptake rate that was calculated using these fluorescence values (See methods) 
was in close agreement with the directly measured glucose uptake rate (Figures 3.8 and 3.11). 
Error bars, s.e.m.; n=3. 
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3.6.  Biological nature of the critical point (µc, rc) 
The critical point (µc, rc) may represent a region of phase transition in the cell’s growth 
and metabolism. The cell dramatically increases its ethanol production rate as its uptake rate 
increases above the critical rate rc (Figure 3.25). This suggests that when its uptake rate is below 
rc, the cell metabolizes glucose largely through respiration, but then switches to a largely 
fermentative metabolism as the uptake rate exceeds rc. A key rate limiting step in fermentation is 
import of glucose and therefore the cell only redirects its glucose flux from respiration to 
fermentation when its glucose uptake rate is sufficiently high30,31. Our results suggest that this 
major redistribution of flux occurs around rc. 
 
Figure 3.25.:  Rate of ethanol production per cell suggests a shift from respiration to 
fermentation near the critical uptake rate rc. Following a procedure essentially identical to the 
one used in measuring the glucose uptake rate (See methods), the average rate of ethanol 
production per cell was measured using a commerical ethanol assay kit (BioVision cat.#K620). 
Shown here are the ethanol production rates of the single-HXT strains with (diamonds) and 
without (circles) Snf3 and Rgt2 grown in various [glucose] (0.006% (red), 0.06% (blue), 0.2% 
(green), and 1% (black)). The ethanol production rates of the wild-type strain (squares) grown in 
these four values of [glucose] are also shown. The sharp increase in ethanol production rate 
indicates a shift from largely respirative to fermentative metabolism near the critical uptake rate 
rc. Error bars, s.e.m.; n=3.  
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3.7.  Growth model sets a constraint on faster growth of yeast 
 When the cell’s glucose uptake rate r is lower than rc, an increase in the extracellular 
glucose concentration causes two counteracting effects (Figure 3.11). First, since the Hxt is a 
passive transporter, it leads to an increased glucose uptake rate (which tends to increase the 
growth rate). Second, it causes the cell to perceive a higher amount of glucose (which tends to 
decrease the growth rate). This counteracting interaction between the two mechanisms – glucose 
perception and uptake – determines how the growth rate changes (i.e., whether it increases or 
decreases) as a result of an increase in the extracellular glucose level. The effect of this 
interaction on the growth rate is quantified by
€ 
P(g)ln rrc
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟  which couples the two mechanisms. In 
particular, if g0 and r0 are glucose concentration and uptake rate of a cell in growth environment 
‘A’, while g1 and r1 are for growth environment ‘B’, then the cell grows faster in environment 
‘B’ than in environment ‘A’ if the following inequality is satisfied: 
                     
€ 
P(g0)ln
r0
rc
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟  < 
€ 
P(g1)ln
r1
rc
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟       [3.2] 
Due to the counteracting nature of the two mechanisms, a higher uptake rate (r0 < r1) and a 
higher glucose level (g0 < g1) do not guarantee that above inequality will hold. This can be 
visualized in the growth landscape (Figure 3.12). 
 
3.8.  Balancing glucose perception and import. 
 While an increase in the amount of glucose in the cell’s surrounding causes the Hxt to 
transport glucose faster due to the passive nature of the Hxt, it also results in the cell perceiving a 
higher amount of glucose that can decrease the cell’s growth rate as seen Figures 3.11 and 3.12 
(unless the cell’s uptake rate is larger than rc).  If the cell wishes to prevent its growth rate from 
decreasing in this situation, it has to not only increase its uptake rate but do so by at least a 
certain minimum amount. The cell can achieve this by changing both the number and type of Hxt 
it makes as a function of glucose. To formalize this notion, let NHXTn(g) be the number of Hxt 
type “n” the cell makes when it senses a particular concentration of glucose g in its surrounding. 
Then the cell’s total uptake rate r is a function r = r({NHXTn(g)}, g) where {NHXTn (g)} is the set of 
all types of Hxts made by the cell. The growth rate µ(({NHXTn(g)}, g)) then is a curve 
parameterized by g: it is a particular “growth trajectory” in the space of all possible growth rates 
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(Fig. 3c). Hence the particular set {NHXTn(g)}, hard-wired into the cell by transcriptional 
regulation of the HXT genes, determines the particular “growth trajectory”. Using the expression 
for growth rate 
€ 
µ(r,g) = P(g)ln rrc
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ + µc
 
obtained in Figure 3.11, the requirement that the cell’s 
growth rate never decreases whenever g increases (dµ/dg 
€ 
≥ 0) means that the following 
inequality has to be satisfied at all points on its growth trajectory: 
 
(Perception)     
€ 
dP dg
P ≤
d ln(r /rc ) dg
ln(rc /r)
 (Import).                      [3.3] 
Those parts of the growth trajectory where above inequality is not met correspond to the cell’s 
growth rate decreasing despite an increase in g. Notice the left hand side of Eqn.[3.3] involves 
only the effect of glucose perception while the right hand side involves only the glucose import.  
Above inequality represents the balance of fractional changes due to these two separate effects. 
Any synthetic rewiring of the transcriptional regulation of the HXT genes, leading to changing 
the set {NHXTi (g)} from the wild-type values, should be done mindful of above inequality: a 
lesson learned from the “single-HXT” strains. 
 
3.9.  Possible molecular mechanisms underlying the effects of glucose perception and 
import 
 Glucose metabolism, involving thousands of chemical reactions and numerous 
intracellular events (gene regulations, post-transcriptional modifications, etc.), is a complex 
process. But the equation for growth rate 
€ 
µ(r,g) = P(g)ln rrc
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ + µc  obtained in Figure 3.11 shows 
us that such a complex set of components can work in concert to yield a simple description. 
Since glucose metabolism involves thousands of intracellular activities ranging from metabolic 
reactions, transcription of many genes, and post-transcriptional modifications, it is difficult to 
pinpoint to a single, or most likely, many correlated molecular events that underlie the 
phenomenological growth model revealed in our study. As a case example, a recent microarray 
study1 has shown that hundreds of genes involved in ribosomal biogenesis, which are 
energetically very costly due to their relatively short half-lives, are up-regulated by many 
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decade-folds as the extracellular glucose concentration is increased from 0.01%, to 0.1%, and 
then to 1% w/vol. Future studies that look at the global expression levels while varying the 
glucose perception and import independently of each other may help in distinguishing what 
fraction of these expression level changes are due to (1) changes in the perception of 
extracellular glucose level as opposed to (2) changes in the glucose import rate. Such a study 
would shine light into the transcriptional regulations that may be responsible for the growth 
effects embodied in our growth model. In addition, a large-scale study that measures the changes 
in the metabolites (using mass spectrometry, for instance) while the cell’s perception and import 
of glucose are varied independently of each other over a wide range will further elucidate what is 
likely to be a vast number of molecular mechanisms underlying the phenomenological growth 
model uncovered in our study. It is well known that glucose-mediated post-transcriptional 
modifications exist, especially of metabolic proteins2. Measuring how these events are affected 
separately by glucose perception and import on a global scale would be difficult but worthwhile. 
Decupling the glucose perception from glucose import in large-scale studies will yield valuable 
insights in understanding the vast molecular events that are likely working in concert to produce 
the phenomenological growth model revealed in our study. 
 
3.10.  Why would the phenomenological model dictate yeast’s growth? 
Glucose perception and import are two separable modules that each affects the growth rate. But 
it is the interaction between the two modules that ultimately determines the cell’s growth rate, 
and that interaction can be both precisely altered and measured. But why would it make sense 
that yeast grows according to Eqn. [3.1], which allows for a possible detrimental growth if the 
interaction between the perception and import modules is not properly tuned? One explanation 
may be that yeast has no way to directly ‘measure’ its glucose import rate in real-time. Indeed, 
there is no known ‘flux sensor’ that the yeast uses to measure its glucose import rate in real-time 
and then adjust the production level of Hxts to change the glucose import rate if the yeast senses 
that the flux is too low.  In fact, Hxt expression levels are primarily set by the extracellular 
glucose concentration32 (Figure 3.11). While yeast certainly can measure the extracellular 
glucose level directly and the intracellular glucose level indirectly (for example, through the 
catabolite-repressor Mig1 which uses intracellular glucose as its substrate)33-35, knowing the two 
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glucose levels is not sufficient for the yeast to infer what its glucose import rate is. This is 
because a given steady-state glucose concentration gradient can be maintained by a combination 
of wide ranges of glucose import rate and intracellular glucose breakdown rate. Since the cell has 
no direct way to measure the breakdown rate (there is no known ‘rate sensor’ measuring 
intracellular glucose breakdown), the cell cannot infer what the glucose import rate is in real-
time just from the difference between extracellular and intracellular glucose. Given the 
engineering difficulty of building ‘flux sensors’, the yeast may have solved the problem by 
evolving glucose sensors such as Snf3 and Rgt2 to measure the extracellular glucose level, then 
anticipate a certain glucose import rate would be achieved, set up intracellular activities to 
process glucose being imported at the anticipated rate, and make sure that such an import rate is 
indeed achieved by putting its HXT genes under the control of those glucose sensors (Figure 
3.11).   
 On-going efforts at large-scale modeling of glucose metabolism, gene regulation36 and 
cellular signaling must decouple and consider how the cell’s response varies when glucose 
uptake rate is varied independently of extracellular glucose level. For instance, microarray 
studies have shown that hundreds of genes involved in ribosomal biogenesis, which are 
energetically very costly, are up-regulated by many folds as the yeast is subjected to ever 
increasing levels of glucose37. In these studies, as the level of glucose is increased, so does the 
glucose import rate. These observed large-scale changes are thus due to the conflated effects of 
glucose perception and import. It would be interesting to measure which of these changes are due 
to glucose perception and import separately by decoupling the two effects. We hope that our 
model, as well as the framework used to extract some key principles from the complexity 
underlying yeast growth, will assist ongoing efforts to rationally engineer38-40 and understand 
microbial metabolism at the systems-level41-48. 
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Summary of experimental methods used 
Strain background and construction. A list of strains with diagrams summarizing their key 
features are provided in the supplementary information section. All strains were derived from the 
haploid strain CEN.PK2-1C (MAT α, kind gift from E. Boles)24, referred to as the “wild-type” in 
our study. Both EBY.VW4000 and EBY.VW5000 are deficient in hexose transport due to 
deletions of all HXT genes as well as genes encoding transporters with minor glucose uptake 
capabilities (agt1Δ ydl247wΔ yjr160Δ)24. HY4D1 and HY5F1 each contain rtTA protein 
expressed constitutively by the MYO2 promoter (inserted into EBY.VW4000 and EBY.VW5000 
respectively using plasmid pDH18 (EUROSCARF) containing HIS5 gene) and CFP 
constitutively expressed by PTEF1. XhoI-PTET07-BamHI, BamHI-HXTn-NotI fragments were 
cloned into pRS305 (EUROSCARF) backbone containing LEU2 gene (n= 1-4, 6).  Integrating 
these plasmids into defective LEU2 locus (leu2-3) in HY4D1 by linearizing the plasmids with 
NarI, the “single-HXT” strains were constructed. To construct fluorescent “single-HXT” strains, 
yEGFP-TADH1-Kan fragment was amplified from pKT127 plasmid (EUROSCARF) and was 
fused to C-terminus of HXTn ORF in each of the single-HXT strains via standard PCR 
integration49. This fragment was also fused to C-terminus of HXTn ORF (n=1-4, 6, 7) in 
CEN.PK2-1C, thus resulting in six fluorescent wild-type strains (Figure 3.24). The “sensorless” 
versions of single-HXT strains (snf3Δ rgt2Δ) were constructed in the same way as their sensor-
intact counterparts mentioned above by using HY5F1 instead of HY4D1. To probe the wild-
type’s transcriptional regulation of each of the HXT genes (Figure 3.1), XhoI-PHXTn-BamHI, 
BamHI-YFP-NotI fragments were cloned into pRS305 backbone containing LEU2 gene (n=1-4, 
7) and was integrated into the defective LEU2 locus (leu2-3) in CEN.PK2-1C by linearizing the 
plasmid with either NarI (for n=1) or ClaI (for all other n), resulting in five strains. The PHXT1, 
PHXT2, PHXT3, PHXT4, and PHXT7 promoter sequences refer to 1941-, 850-, 1996-, 1544-, 2042-bp 
upstream of the start codon of the respective genes. These sequences include all the known 
binding sites of transcription factors for the respective genes50. 
 
Growth rate measurements. All growth rates reported in our study were measured while the 
cells were in log-phase growth in 5 mL batch cultures at 30 oC, in a standard synthetic media 
with various combinations of glucose and doxycycline concentrations. To bring the cells into 
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log-phase, the single-HXT strains were first grown in a standard synthetic media containing 2% 
maltose and the desired concentration of doxycycline until the cells have been in log-phase for 
roughly 12 hours. This procedure ensured that the cells were already making Hxts needed to 
initiate glucose uptake immediately after being transferred to glucose media. Then these cells 
were diluted into the standard synthetic media with the same amount of doxycycline, but this 
time containing glucose instead of maltose. These dilutions were done such that by the time the 
density of cells in the batch culture reached level detectable by our spectrophotometer (Hitachi 
U-1800) (roughly 15 hours after dilution), the cells had adjusted to the glucose media and were 
in log-phase growth. Hence, the transient growth rate change associated with maltose to glucose 
media transfer did not enter into our growth rate measurements.  In a separate experiment, we 
confirmed this was indeed the case by further diluting these cultures into an identical glucose 
media, which showed that having the cells pre-grown in maltose before did not affect the growth 
rates reported in our study.  By measuring the Optical Density (OD600 : Absorbance at λ = 600 
nm) of these batch cultures over time, we extracted the growth rate of the cells. Strains that 
approached growth arrest also went through the same procedure as above. Upon transfer to 
glucose media from maltose media, these cells’ growth rates transiently decreased to nearly zero 
during a period of roughly 24 hours. By looking at the cells under the microscope, no abnormal 
cell morphologies were detected, thus indicating normal growth (i.e. no pseudohyphal or 
filamentous growth was detected). 
 
Fluorescence measurements. The average single-cell fluorescence due to yEGFP fused to C-
terminus of HXT genes in both the wild-type and the single-HXT strains was measured using a 
Becton Dickinson FACScan flow cytometer with excitation laser at 488nm. Emission filter FL1 
(530/30) was used to detect the yEGFP fluorescence levels as well as the YFP for determining 
the PTET07 induction curves in the calibration strains HY4DCal5 and HY5FCal2. Before 
observation using FACscan, the strains were grown using the protocol outlined in “growth rate 
measurements” section.  The mean fluorescence values reported in our study represent the 
steady-state levels of Hxt proteins in single cells, since no appreciable changes in fluorescence 
was detected while the cells were growing in log-phase. 
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Glucose uptake rate measurements and calculations. Glucose uptake rates of cells were 
determined by measuring the rate of glucose depletion in the growth medium while the cells 
were in log-phase growth. First, the reasoning behind this procedure is as follows: If the cell’s 
growth rate at glucose concentration G0 is µ, G(t) is the concentration of glucose in the growth 
medium at time t, r(G(t)) is the uptake rate per OD of the cells as a function of extracellular 
glucose, and r0 is the OD of cells at t = 0, then the decrease in glucose concentration in the 
growth medium over time t is 
 
€ 
G0 −G(t) = r(G(τ ))ρ0 exp(µτ)dτ
0
t
∫ .       [3.4] 
If this change in glucose concentration is sufficiently small, but large enough to be detectable by 
our chemical assay (described below), then we can approximate r(G(t))
€ 
≈  r(G0) and µ as a 
constant during the time interval t. Then above equation can be solved for r(G0): 
€ 
r(G0) ≈ µ
(G0 −G(t))
ρ(t) − ρ0
,       [3.5] 
where r(G0) is the uptake rate per OD600, measured in units of mM hr-1 OD600-1.  This was then 
converted into molecules sec-1 cell-1 using conversion factor 1.7 x 107 cells ml-1 OD600-1. ρ(t) - ρ0 
is the change in OD600 of the cells measured using the spectrophotometer (Hitachi U-1800), and 
µ is the growth rate determined by the method mentioned previously. The change in glucose 
concentration G0 – G(t) was measured using the standard commercial glucose assay kit (Sigma 
G3293) based on conversion of glucose through hexokinase and NADP+ dependent glucose-6-
phosphate-dehydrogenase. We compared the measured glucose uptake rates with the uptake rates 
calculated using an independent method for the fluorescent single-HXT and wild-type strains. 
We calculated the glucose uptake rates by using the known Michaelis-Menten parameters (Vm 
and Km) of Hxts26 and the relative number of Hxt proteins per cell inferred from measuring the 
average single-cell yEGFP fluorescence (Supplementary Information). These comparisons 
showed a close agreement between our measured and calculated uptake rates (Figures 3.8 and 
3.22). 
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PTET07
HXTn
Doxycycline Glucose
PTET07
HXTn yEGFP
yEGFP
Strains used in this study:
HY4D1 LEU2 P       : HXTTET07
       Strain name 
HXT1   H1C3
HXT2   H2C1
HXT3   H3C1
HXT4   H4C9
HXT6   H6C4
“Single-HXT” strains “Single-HXT::yEGFP” strains
“Single-HXT” strain Kan   HXT ::yEGFP R
           Strain name 
HXT1   H1C3Fus14
HXT2   H2C1Fus18
HXT3   H3C1Fus32
HXT4   H4C9Fus1
HXT6   H6C4Fus20
Snf3p / Rgt2p
PTET07
HXTn yEGFP
HY5F1 LEU2 P       : HXTTET07
       Strain name 
HXT1   H1NS2
HXT2   H2NS5
HXT3   H3NS5
HXT4   H4NS2
HXT6   H6NS2
“Single-HXT” strains (Sensor-less) “Single-HXT::yEGFP” strains 
(Sensor-less)
“Single-HXT” strain Kan   HXT ::yEGFP R
           Strain name 
HXT1   H1NS2Fus30
HXT2   H2NS5Fus4
HXT3   H3NS5Fus2
HXT4   could not be made
HXT6   H6NS2Fus22
(Sensor-less)
PTET07
HXTn
Snf3   &  Rgt2 Snf3   &  Rgt2
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Strains used in this study (Continued):
CEN.PK2-1C LEU2  P      :HXTHXTn
       Strain name 
HXT1   H1S1
HXT2   H2S2
HXT3   H3S1
HXT4   H4S2
HXT7  H7S2
Wild-type P      :YFP Wild-type HXTn::yEGFP
CEN.PK2-1C Kan   HXT ::yEGFP R
           Strain name 
HXT1   CenH1Fus10
HXT2   CenH2Fus5
HXT3   CenH3Fus4
HXT4   CenH4Fus10
HXT6   CenH6Fus10
HXT7   CenH7Fus15
PHXTn
HXTn yEGFP
HXTn
PHXTn
 YFP
Strains for studying P         induction:TET07
Notes
Used in Fig. S2.
Used in Fig. S10.
Others:
Strain name  Genotype       Notes
HY4D1     EBY.VW4000 HIS5 P      :rtTA        Common parent for all “single-HXT” strains (with sensors)
HY5F1     EBY.VW5000 HIS5 P      :rtTA        Common parent for all “single-HXT” strains (snf3Δ rgt2Δ)
EBY.VW4000    (See Reference*)             hxt1-17Δ RGT2 and SNF3 intact. Gift from E. Boles.
EBY.VW5000    (See Reference*)        hxt1-17Δ rgt2Δ snf3Δ. Gift from E. Boles.
CEN.PK2-1C     (See Reference*)        “Wild-type” used in this study. Gift from E. Boles. 
* R. Wieczorke, S. Krampe, T. Weierstall, K. Freidel, C. Hollenberg, and E. Boles. 
  “Concurrent knock-out of at least 20 transporter genes is required to block uptake of hexoses in 
   Saccharomyces cerevisiae”, FEBS Letters, 464 (3), 123-128 (1999).
MYO2
MYO2
Note: EBY.VW4000 and EBY.VW5000 are both unable to grow on glucose since all HXTs as well as genes for
transporters with minor glucose uptake capability had been deleted ( hxt1-17Δ agt1Δ stl1Δ gal2Δ ).
HIS5
HIS5
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4. Embryonic stem cells: A brief overview 
  
Chapter summary 
 
 In this chapter, we introduce some basic facts about mouse embryonic stem cells. We 
outline historical developments, common experimental techniques, and important discoveries. 
This chapter provides the necessary background to understand our experiments in chapter 5. 
4.1. Historical overview 
 In the early 1960s, groundbreaking experiments by biophysicists James Till and Ernest 
McCulloch, then working at the University of Toronto, established the existence of stem cells for 
the first time. At the time, they were studying leukemia and the formation of normal blood cells. 
By using a novel quantitative method for identifying monoclonal population of cells, the two 
researchers injected bone marrow cells into irradiated mice. A small swelling due to an aggregate 
of cells, called ‘nodules’, formed in the spleens of the mice as a result of their injection [1, 2]. 
They showed that the number of nodules formed was proportional to the number of bone marrow 
cells that were injected into the mouse. They called these nodules ‘spleen colonies’ and 
hypothesized that each nodule arose from a single marrow cell. They hypothesized that a single 
marrow cell could self-renew and differentiate into different cell types, giving rise to the nodules. 
Together with their graduate student Andy Becker, they demonstrated that each nodule indeed 
arose from a single cell [3].  Later work with Lou Siminovitch showed that these cells could self-
renew [4]. These works demonstrated that a stem cell (called ‘mesenchymal stem cell’) exists 
within the bone marrow, as self-renewal and multipotency are the hallmarks of stem cell. 
Specifically, Till and McCulloch had found a tissue-specific, adult stem cell. These can form 
either one (unipotent adult stem cell) or a few specific types of cells (multipotent adult stem cell) 
in the body.  
 Embryonic stem cells are pluripotent: They can differentiate into almost all the major cell 
types that make up the body. An early (< 5 days for mice and humans) embryo exists as a small 
(about 0.1 mm in diameter) sac of fluid and cells (Figure 4.1).  A layer of cells, known as 
trophectoderm, shields the inner cell mass (ICM) and fluid inside the blastocyst.  
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Figure 4.1: Blastocyst during early mammalian embryogenesis. The inner cell mass can be 
extracted from the mouse blastocyst and cultured as self-renewing, pluripotent cells in a petri 
dish. These cells are known as embryonic stem cells. (From Wikimedia commons). 
 
 
 
The trophectoderm will eventually form the placenta. The ICM, when extracted from the 
blastocyst, can be cultured in  petri dish as self-renewing, pluripotent cells known as embryonic 
stem cells. Martin Evans, Matthew Kaufman, and Gail Martin have discovered such a method in 
1981 [5,6]. They succeeded in isolating embryonic stem cells from mouse blastocysts and 
growing them in cell culture. One of the first applications of embryonic stem cells cultured this 
way was in making ‘knockout’ mice. In these mice, specific gene has been knocked out of the 
mouse genome. This is typically done by mutating or excising a gene of interest in the 
embryonic stem cell, then injecting the cell into a mouse blastocyst. This blastocyst eventually 
gives rise to a mouse with the targeted gene knocked out. These genetically altered mice have 
since been widely used as models for studying progression of wide range of human diseases such 
as cancer, diabetes, cystic fibrosis, and arthritis. Human embryonic stem cells have not been 
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isolated until 1998, when the groups of James Thomson and John Gearhart independently 
discovered a method for isolating the ESCs from human embryos [7,8]. Although there are 
differences between human and mouse embryonic stem cells, they share many primary features. 
This allows researchers to use mouse embryonic stem cells to draw meaningful conclusions 
about human embryonic stem cells, which are more difficult to work with for technical and 
ethical reasons. 
 
4.2. Conventional experimental toolkits for studying pluripotency transcriptional network 
 An embryonic stem cell is a precursor cell that can grow into every kind of mammalian 
tissue; including muscle, bone, and brain. At the moment, only mice and human embryonic stem 
cells can be isolated and studied. It is difficult to pinpoint exactly what network of proteins are 
responsible for maintaining a stem cell in this uncommitted state. Genome wide studies have 
revealed the immense complexity of the transcriptional state of the pluripotent stem cell.  Below, 
we detail current genome-wide experimental techniques and what they have found. We will then 
explain what single-cell level studies of transcripts can tell us that such genome scale approaches 
may overlook. 
 First we introduce some basic experimental tools that are used for measuring the genome 
wide transcriptional state of a population of cells. 
(i).  DNA Microarray 
 DNA microarray is a device that measures the average expression level of a large number 
of genes.  In this device, a population of cells is first lysed, from which all the mRNA molecules 
within the population of cells are gathered. Each mRNA is then reverse transcribed into its 
cDNA (complementary DNA), which would exclude all the introns since the mRNA results after 
splicing). This cDNA is then introduced to a small well, at the bottom of which is a small (about 
one picomole) amount of fluorescently tagged ‘probe’ DNA that would complementarily bind 
the cDNA of interest.  The intensity of florescence in the well is proportional to the number of 
cDNA that is bound to the probe DNA in the well. This florescence thus quantifies, on average, 
how much abundant the mRNA of a particular gene within the population of cells.  Nowadays, 
DNA microarray ‘chip’ can have many wells, enough to measure expression levels of the entire 
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genome of some organisms (~6,000 genes for the budding yeast), and is a routine tool for 
researchers. 
(ii.) Chromatin ImmunoPrecipitation (ChIP) 
 Chromatin ImmunoPrecipitation (ChIP) allows researchers to identify proteins that 
interact with a particular sequence of DNA within a cell such as transcription factors. In this 
procedure, one first crosslinks all the polypeptides within a cell by using a fixative like 
formaldehyde. This is analogous to hard-boiling an egg, in which  the inside contents of the egg 
are preserved, with its yolk fixed in its place. The fixed cells are then lysed and only the 
chromatins and any proteins that are bound to any region of the chromatin are extracted from this 
lysate. These proteins come down along with the chromatin due to the fixation step mentioned 
above. By sonication, the chromatin is fragmented into smaller pieces with the proteins still 
bound to them. To check which region of DNA a specific protein of interest is bound, antibody 
specific to that protein is conjugated to the protein. An additional purification step purifies only 
those DNA sequences that are bound to the antibody-protein complex for analysis. 
(iii.) ChIP-chip  
 ChIP-chip (also known as ChIP-on-chip) combines ChIP with the DNA microarray 
technology. This is a high-throughput version ChIP-Seq, in which all putative segments of DNA 
within the cell’s genome can be obtained by ChIP, then sequenced using a whole-genome 
microarray chip. Since DNA microarray can quantify the relative amounts of a particular DNA 
sequence, it allows gives some quantitative information about frequency with which a particular 
protein binds to the sequence within a population of cells. 
(iv.) ChIP-Sequencing (ChIP-Seq) 
 Combining ChIP with high-throughput nucleotide sequencing gives rise ot ChIP. By 
sequencing the pieces of DNA that is pulled down with the antibody-protein complex at the end 
of the ChIP procedure, one can identify regions of DNA that a given protein has a measurable 
affinity for binding. This technique thus helps with unraveling a putative transcriptional network 
through identifying possible transcription factors and their binding locations in the genome.  This 
method, however, does not discriminate between proteins that are bound to a promoter region 
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while the gene controlled by that promoter is transcriptionally inactive, from those proteins that 
are actually bound to the promoter during the gene is transcriptionally active. 
4.3. Current understanding of the pluripotency transcriptional network 
 If there is one finding about pluripotency transcriptional network that almost all 
researchers will agree on, it is that the network involves many genes, potential transcription 
factors, and intricate chromatin states that we do not yet fully understand. Aside from the shear 
complexity of the transcriptional network that maintains the stem cell’s pluripotency, many 
conflicting reports and round-about experiments have caused much confusion and disagreements 
among the researchers in the field. Even the ‘pluripotency transcriptional network’ is not well 
defined due to these complications. A simplified network of important transcription factors still 
contains a fairly large number of unknown connections and genes (Figure 4.2) [9]. In almost all 
the models of transcription networks that researchers propose, Oct4, Sox2, and Nanog form a 
core ‘trinity’ of regulators. For this reason, our work in chapter 5 will study these three players in 
detail. 
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 Figure 4.2.: One model of a ‘core’ embryonic stem cell regulatory circuitry. Depending on 
the choice of literature, other players may be added or removed from the list of genes shown 
here. But many agree that Oct4, Sox2, and Nanog form a core ‘trinity’ of regulators. (Adapted 
from Jaenisch and Young, Cell 132, 567-582 (2008) [9]). 
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Primary transcription factors maintain pluripotency 
 A growing list of studies now pinpoint to three nuclear ‘master’ regulators, Oct4, Sox2, 
and Nanog as essential for maintaining pluripotency in vivo and in vitro [10]. From ChIP-Seq 
studies, researchers found that these three proteins show binding affinity for a large set of 
promoter regions, potentially affecting the their transcription.  And since many of their target 
genes code for transcription factors that may also bind to the promoters of Oct4, Nanog, and 
Sox2, researchers believe that a complex transcriptional network governed by many transcription 
factors are responsible for maintaining the pluripotent state of an embryonic stem cell. In 
addition, Oct4, Nanog, and Sox2 each binds to its own promoter, thus adding complexity to an 
already intricate network.   
Role of Nanog in embryonic stem cells:  
 Recent single-cell level studies of embryonic stem cells, particularly by the group led by 
Austin Smith, have shown that expression level of Nanog varies highly from cell-to-cell within a 
population of cells growing in the same petri dish.  A stem cell can persist in culture when both 
copies of Nanog alleles are deleted from the cell’s genome.  This cell, however, shows a 
markedly reduced self-renewal efficiency and an increased likelihood to differentiate into 
primitive endoderm-like cells [11]. By injecting Nanog -/- cells are injected into the early mouse 
embryo, researchers found that primordial germ cells failed to mature. The role of Nanog is now 
believed to be primarily in constructing the inner cell mass and germ cells.  At the other extreme, 
researchers found that overexpressing Nanog results in inhibition of differentiation into certain 
cell types. These findings, together establish that Nanog is indispensible in the mouse embryonic 
development and is important in maintenance of pluripotency of embryonic stem cells. Crucially, 
these findings indicate that a finely maintained expression level of Nanog may be important in a 
stem cell. 
Role of Oct4 in embryonic stem cells: 
 Oct4 is an oncogene. This means that its overexpression aids in turning a normal cell into 
a tumor cell. This means that its overexpression may potentially interrupt stem cells function. At 
the same time, its expression level is necessary for the stem cell to remain pluripotent. This 
trade-off is a theme that we will come back to in the next chapter. 
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 An ectopic overexpression of Oct4 in a mouse embryo inhibits proper differentiation into 
epithelial tissues [12]. By overexpressing Oct4 in somatic tissue cells in adult mice, researchers 
showed that abnormal, dysplastic growth results in the affected tissues, reminiscent of 
tumorigenesis. During differentiation into endoderm [12] and neurectoderm of the embryo, Oct4 
expression is gradually shut down. Researchers have also shown that a loss-of-function mutation 
for Oct4 results in early embryonic lethality due to inappropriate differentiation of pluripotent 
epiblast cells into trophectoderm [12]. Turning down the level of Oct4 expression in mouse 
embryonic stem cells results in in trophectoderm differentiation, where as overexpression 
induces differentiation into exraembryonic mesoderm and endoderm. Thus varying the dosage of 
Oct4 expression corresponds to varying the cell fate of the embryonic stem cell.  After Oct4 is 
turned off, by turning it on in certain somatic cells, researchers have seen dedifferentiation of the 
somatic cell. A two-fold increase in Oct4 expression level causes embryonic stem cells to 
differentiate into endoderm and mesoderm, whereas knockdown of Oct4 causes the embryonic 
stem cells to enter into trophectoderm-like cells [13]. 
Role of Sox2 in embryonic stem cells: 
 Accumulating evidence now pinpoint Sox2 to be a master regulator that controls the 
expression levels of developmentally important genes such as Oct4, Nanog, nestin, and FGF4. 
Sox2 also binds to its own promoter region, suggesting that it autoregulates itself along with 
other transcription factors that bind there.  These studies indicate that perturbing Sox2 expression 
level would result in potentially a large number of genes being affected.  A loss-of-function 
mutation in Sox2 results in loss of pluripotency in embryonic stem cells.  A recent study showed 
that ectopically overexpressing Sox2 gene results in differentiation of embryonic stem cells into 
cells that display markers for a variety of different cell types (neuroectoderm, mesoderm, and 
trophectoderm) but not including those associated with endoderm. Interestingly, a recent work 
showed that ectopically overexpressing Sox2, in a related type of cell known as embryonic 
carcinoma cells, results in downregulation of the endogenous Sox2 expression level. Since both 
embryonic carcinoma cell (F9 EC) and embryonic stem cells share the same Sox2:Oct3-4 target 
genes and their expression levels turn off when both differentiate, this result may be apply in the 
embryonic stem cells as well [14]. We will show how to test this prediction in chapter 5. As with 
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Nanog and Oct4, these results together indicate that Sox2 expression level may need to remain 
within a certain range in order for the stem cell to remain pluripotent. 
4.4. A need for a phenomenological understanding of pluripotency circuitry 
 There is a mounting list of novel mechanisms and more detailed understanding of the 
already known molecular events that are important for transcriptional maintenance of 
pluripotency. But an alternative approach, one in which less attention is paid to the exact 
molecular details and pays attention to a few parameters that capture the essence of the system 
instead, may improve our understanding. In addition, a non-invasive technique for measuring the 
transcriptional state of the cell, one that does not require genetic manipulation or lysing of many 
cells, may be important for studying stem cells given the intricacies that we know are lost during 
invasive techniques such as fluorescent protein fusion and cell lysis. Chapter 5 describes our 
early work towards reaching such a phenomenological understanding of the pluripotency 
transcriptional circuitry using a non-invasive technique.s 
 	  
95
Bibliography for Chapter 4 
 
[1.] McCulloch, E. A., and Till, J. E. The radiation sensitivity of normal mouse bone marrow 
 cells, determined by quantitative marrow transplantation into irradiated mice. Radiation 
 Research 13, 115-125 (1960). 
 
[2.] Till, J. E., and McCulloch, E. A. A direct measurement of the radiation sensitivity of 
 normal mouse bone marrow cells. Radiation Research 14, 213-222 (1961). 
 
[3.] Becker, A. J., McCulloch, E. A., and Till, J. E., Cytological demonstration of the clonal 
 nature of spleen colonies derived from transplanted mouse marrow cells.  
 Nature 197, 452-454 (1963). 
 
[4.] Till, J. E., McCulloch, E. A., and Siminovitch, L. A stochastic model of stem cell 
 proliferation, based on the growth of spleen colony forming cells.  
 Proc Natl Acad Sci. 51, 29-36 (1964). 
  
[5.] Evans, M., and Kaufman, M. Establishment in culture of pluripotent cells from mouse 
 embryos. Nature 292, 154-156 (1981). 
 
[6.] Martin, G. Isolation of a pluripotent cell line from early mouse embryos cultured in 
 medium conditioned by teratocarcinoma stem cells.   
 Proc Natl Acad Sci 78, 7634-7638 (1981). 
 
[7.] Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts.  
 Science 282, 1145-1147 (1998). 
 
[8.] Shamblott, M. J. et al. Derivation of pluripotent stem cells from cultured human 
 primordial germ cells. Proc Natl Acad Sci 95, 13726-13731 (1998). 
 
[9.] Jaenisch, R., and Young R., Stem cells, the molecular circuitry of pluripotency and 
 nuclear reprogramming. Cell 132, 567-582  (2008). 
 
[10.] Niwa, H. How is pluripotency determined and maintained? Development 134, 635-646 
 (2007). 
 
[11.] Chambers, I. et al. Nanog safeguards pluripotency and mediates germline development.  
 Nature 450, 1230 -1234 (2007). 
 
[12.] Hochedlinger, K., Yamada, Y., Beard, C., and Jaenisch, R. Ectopic expression of Oct-4 
 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121 
 465-477 (2005). 
 
[13.] Niwa, H., Miyazaki, J.-I., and Smith A. G., Quantitative expression of Oct-3/4 defines 
 differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics 24, 372-376 
96
 (2000). 
 
[14.] Boer, B. et. al. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic 
 stem cells inhibits the expression of Sox2:Oct-3/4 target genes.  
 Nucleic Acids Research 35, 1773-1786 (2007). 
 
 	  
97
5. Towards a phenomenological model of transcriptional 
maintenance of pluripotency 
 
Chapter summary 
 A major conceptual question in developmental biology is how an embryonic stem cell 
maintains a pluripotent state that affords the stem cell the flexibility to turn into any major cell 
type in the body. We may obtain insights into this question by systematically perturbing the key 
players of the transcriptional network that is responsible for maintaining pluripotency. Using a 
nascent technique for measuring integer counts of individual mRNA molecules within single 
cells in situ, we can examine cell-to-cell variability in transcriptional response to such 
perturbations in mouse embryonic stem cells. This method also allows for measurement of the 
endogenous transcript levels without the invasive genetic engineering of the embryonic cells. 
This chapter describes our early work towards understanding such transcriptional responses in 
single embryonic stem cells. In particular, we show that increasing the expression level of Nanog 
can have an intricate transcriptional response by Oct4, Sox2 and Nanog itself at the single-cell 
level. In particular, we demonstrate that if Nanog expression level is increased above a certain 
threshold, as yet unknown mechanism is activated in which the level of Nanog expression level 
is quickly shut down. When the Nanog expression level is increased above the endogenous level 
but below the threshold, both Oct4 and Sox2 transcript levels increase in proportion to Nanog. 
We hypothesize possible mechanisms to explain these observations and suggest future 
experiments to test them. 
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5.1. Introduction 
 Pluripotency, the ability of a cell to turn into any of the cell types that make up the 
organism, is one of the hallmarks of embryonic stem cells. A major conceptual question is how 
the complex network of transcriptional circuits maintains the pluripotent state that affords the 
stem cell the flexibility to turn into any major cell type in the body. To acquire a better 
understanding of this question, we can systematically perturb the levels of some key proteins in 
the transcriptional circuitry involved in pluripotency maintenance. We can then measure the 
cell’s transcriptional response by measuring the integer counts of key transcripts, in single mouse 
embryonic stem cells. To do this, we use a nascent technique for directly visualizing individual 
mRNA molecules in stiu within single cells, by fluorescence microscopy (known as “RNA 
FISH”). In doing so, we may discover interesting patterns of cell-to-cell variability in RNA 
levels of key genes in the pluripotency network (notably Nanog, Sox2, and Oct4). Furthermore, 
we can reveal relationships between the transcriptional response of each key gene to 
perturbations of the others and the role of cell-to-cell variability in this response. Our goal is to 
develop a quantitative model that will explain these observations.  Below, we describe our early 
work towards achieving this goal. 
 
5.2. RNA FISH 
 Fluorescence In Situ Hybridization (FISH) is a method that has allowed researchers to 
look at both the endogenous mRNA (RNA FISH) and DNA (DNA FISH) (Gall, 1968; Levsky 
and Singer 2003).  FISH has been applied to a wide range of organisms, from yeast to human 
cells.  It first requires the cells to be fixed, in which all the polypeptides within the cell are 
crosslinked using a fixative such as formaldehyde. A good analogy to fixing a cell is boiling an 
egg, in which the inside contents of the egg are spatially preserved. We then design fluorescently 
labeled single-stranded oligonucleotide sequence that will complementarily bind to the single-
stranded RNA or DNA of interest. By fluorescence microscopy, one can then look at the spatial 
localization and total counts of the fluorescence. DNA FISH has been widely used for looking at 
chromosomal abnormalities, species identification, and chromosomal substructures such as 
looping between two loci. RNA FISH has been used for observing spatial localization of mRNA 
within single cells, and quantifying the absolute counts of mRNA molecules.  
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 The particular version of RNA FISH we use in this chapter is a modification of the RNA 
FISH method described by Robert Singer and his coworkers (Femino et al, 1998). In this 
method, we use a large collection (at least 30) of single-stranded oligonucleotides, each labeled 
with a single fluorophore, that binds along the length of the target mRNA (Figure 5.1a). The 
binding of so many fluorophores to a single mRNA results in a signal that is bright enough to be 
detectable with an epi-fluorescence microscope as a diffraction-limited spot.  
 We have designed RNA FISH probes that target Nanog, Sox2, and Oct4 endogenous 
mRNA molecules.  Each transcript has forty-eight probes, each of which are attached to a single 
fluorophore molecule. We used three different fluorophores (Cy5, Alexa594, and TMR) whose 
excitation and emission spectral peaks do not overlap, to label the probes for each gene with a 
different color.  We could thus observe the three different kinds of mRNA molecules (Nanog, 
Sox2, and Oct4) within the same single cell and distinguish them from each other (Figures 5.1b 
and 5.1c). After computationally identifying all the diffraction-limited spots in  a field of view 
under a microscope, we determine which cells each spot belongs to by identifying cell 
boundaries by hand (Figure 5.2). We could thus obtain the absolute counts of mRNA molecules 
in individual stem cells. 
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(a) 
 
  (b)  (c)  
Figure 5.1: RNA FISH applied to mouse embryonic stem cells. (a). Each mRNA molecule is 
targeted by 30 or more probes. Each probe is attached to a single fluorophore molecule and 
consists of about 20 oligonucleotide bases. These 30 or more probes then bind along the stretch 
of the single target mRNA molecule. The bindingof so many fluorophores to a single mRNA 
results in a signal that is bright enough to be seen as a diffraction-limited spot using an epi-
fluorescence microscope. (b). Oct4 mRNA molecules are seen as diffraction limited spots within 
a single mouse embryonic stem cell. (c). Nanog mRNA molecules are seen as diffraction limited 
spots within the same single cell seen in (b). Having Nanog and Oct4 probes labeled with two 
different fluorophores that do not cross-talk, we can distinguish mRNA molecules of Nanog 
from those of Oct4. 
target mRNA
3’ 5’
fluorophore probe
101
  
 
Figure 5.2: Cell segmentation by hand to identify each cell within a population of 
embryonic stem cells. (Left) DAPI staining of a cell’s nucleus helps with identifying individual 
cells in the field of view. (Right) By hand, each cell’s hypothetical boundary is drawn.  
DAPI
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 5.3. Single-cell distrbutions of Nanog, Oct4, and Sox2 transcript counts 
 By measuring the integer counts of the Nanog, Sox2 and Oct4 mRNA molecules within 
the same single cell, and doing this for every cell making up the population of the wild-type 
(V6.5) mouse embryonic stem cells, we obtained a single-cell histogram of each of the three 
types of transcripts (Figure 5.3). Nanog transcript is nearly exponentially distributed, with most 
of the cells within a population (~ 60%) having less than fifty counts. Oct4 transcript level could 
be fit well by a Gaussian distribution, with mean of about 250 transcripts per cell. Sox2 transcript 
distrubiton can be fit with a gamma distribution (in fact, so can Nanog and Oct4 since 
exponential and Gaussian distributions are special cases or limits of gamma distribution). Each 
of the three transcripts thus show their characteristic distributions that are distinct from each 
other.  The fact that we can fit these single-cell transcript distributions is consistent with models 
for transcriptional bursting (Raj et al, 2006; Friedman et al. 2006). Although a detailed study that 
measures various rates relevant for transcriptional dynamics is an interesting study on its own, 
our focus is on coming up with simpler models that capture the relationships between these three 
transcripts that does not involve the level of molecular details that transcriptional bursting 
models invoke.  Since we counted the number of Nanog, Sox2 and Oct4 transcripts all within the 
same single cell, we could look for any possible correlations between any two transcript levels. 
We found that given the cell-to-cell heterogeneity in the levels of all three transcripts, linear 
regression fits provided a poor description of the pluripotent transcriptional state of any one cell. 
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Figure 5.3: Heterogeneities in expression levels of Nanog, Sox2 and Oct4 in the wild-type 
embryonic stem cells (V6.5) are captured by measuring single mRNA molecules within 
single cells. We measured transcripts in 500 stem cells for these histograms. 
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Figure 5.4. Correlations between Nanog, Oct4, and Sox2 transcript levels in wild-type 
(V6.5) embryonic stem cells. Red line is a linear regression fit. Given the cell-to-cell 
heterogeneity in all three transcript levels, linear regression fits clearly provide a poor description 
of the pluripotent transcriptional state of any one cell. 
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5.4. Perturbing pluripotency transcriptional network: Overexpression of Nanog 
 Perturbing the key parameters of a transcriptional network can reveal novel connections 
between genes within the network as well as the underlying design principles. In the case of the 
transcriptional network responsible for pluripotency maintenance, many of the genes that make 
up the network are known but not much is known about their connections.  For example, while 
some studies have shown the effects of over and underexpressing Nanog on the change in the 
average expression level of other genes, our measurement of the wild-type’s transcript 
distributions show that the average gene expression level does not tell the whole story.  For 
example, consider all the cells within a population that have less than 50 Nanog transcripts. 
Some of these cells will have very high Oct4 transcript level (around 300 Oct4 mRNA), while 
some will have nearly half that many Oct4 mRNA (around 150 Oct4 mRNA) (Figure 5.4). This 
type of variability is completely missed by population level studies of transcription network 
perturbations. 
 Motivated by our observation that a correlation plot involving Nanog shows interesting, 
albeit a bit subtle, features (Figure 5.4), we began our network perturbation study with 
overexpresion of Nanog.  A cell line has been constructed by Rudolf Jaenisch’s lab, which 
allows for an ectopic overexpression of Nanog gene. In the V6.5 cell line, researchers have 
homologously recombined the FRT-hygro-polyA cassette downstream of the ColA1 (Collagen) 
locus. When the Flpase enzyme is present, the FRT sites recombine to add the gene in the 
targeting vector into where the FRT site is in the genome.  These cells responded to an increase 
in the concentration of the inducer doxycycline by increasing their Nanog expression level. We 
cultured this inducible-nanog cell line in various concentrations of doxycycline ([dox] = 0.05, 
0.5, 2, 6 ug/ml), and measured the changes in Nanog, Oct4, and Sox2 transcript levels in 
individual cells over five days. These time course experiments yielded intriguing findings. First, 
tracking the change in Nanog distribution over the five days of doxycycline induction (Figure 
5.5) at a relatively low concentration of doxycycline ([dox] = 0.5 ug/ml) shows that the total 
Nanog distribution stabilizes around the third day of induction: minimal changes occur in the 
Nanog distribution between the third and fifth days of induction. In response to the increase in 
the average Nanog transcript level, Oct4 and Sox2 both increase slightly (Figure 5.6). Second, 
tracking the change in Nanog distributions (Figures 5.7-5.8) show that for relatively high 
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concentration of doxycycline ([dox] = 2 ug/ml and 6 ug/ml), the total Nanog transcript level is 
transiently increased and is then turned down after one day of constant doxycycline induction. 
Correspondingly, the average expression level of Oct4 and Sox2 are transiently increased in 
proportion to Nanog, and is then decreased together (Figures 5.9-5.10).  By the fifth day of 
doxycycline induction, Sox2 and Oct4 single-cell transcript distributions show that they have 
noticeably changed compared to the zeroth day distribution  (Figure 5.11): Cells that expressed 
relatively high levels of Sox2 and Oct4 transcripts no longer exist in the new distribution that the 
cells reached on the fifth day of constant doxycycline induction. We do not yet know a possible 
mechanism behind this change in distribution. Given the background information we presented 
in the previous chapter, it would not be surprising if there are intricate mechanisms such as 
RNAi that may be ‘turned on’ when the cell detects that the total Nanog transcript level goes 
above a certain threshold. Whatever the mechanism may be, our experiments clearly demonstrate 
that the cell somehow detects Nanog transcript or protein level going above a certain level. 
Future work may follow up on unraveling this mechanism. 
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Figure 5.5: Changes in distribution of Nanog transcript in single stem cells after an ectopic 
overexpression of Nanog; ([doxyclicine] = 0.5 ug/ml). 
 
 
 
 
 
 
 
 
 
 
0 50 100 150 200 250 3000
5
10
15
20
25
30
35
Nanog Transcript Counts
%
 o
f p
op
ul
at
io
n
wild-type
0 50 100 150 200 250 3000
5
10
15
20
25
30
35
Nanog Transcript Counts
%
 o
f p
op
ul
at
io
n
[dox] = 0.5 ug/ml; Day 5.5
0 50 100 150 200 250 3000
5
10
15
20
25
30
35
Nanog Transcript Counts
%
 o
f p
op
ul
at
io
n
[dox] = 0.5 ug/ml; Day 1
0 50 100 150 200 250 3000
5
10
15
20
25
30
35
Nanog Transcript Counts
%
 o
f p
op
ul
at
io
n
[dox] = 0.5 ug/ml; Day 3
108
  
Figure 5.6: Changes in Oct4 and Sox2 as a result of the doxycycline-induced ectopic 
expression of Nanog. Different colors indicate ‘snapshots’ of different days during a constant 
doxycycline-induction: Day 0 (Green), Day 1 (Black), Day 3 (Blue), Day 5 (Red). 
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Figure 5.7: Changes in distribution of Nanog transcript in single stem cells after an ectopic 
overexpression of Nanog; ([doxyclicine] = 2 ug/ml). 
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Figure 5.8: Changes in distribution of Nanog transcript in single stem cells after an ectopic 
overexpression of Nanog; ([doxyclicine] = 6 ug/ml).
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Figure 5.9: Changes in Oct4 and Sox2 as a result of the doxycycline-induced ectopic 
expression of Nanog; [dox] = 2 ug/ml. Different colors indicate ‘snapshots’ of different days 
during a constant doxycycline-induction: Day 0 (Green), Day 1 (Black), Day 3 (Blue), Day 5.5 
(Red). 
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Figure 5.10: Changes in Oct4 as a result of the doxycycline-induced ectopic expression of 
Nanog; [dox] = 2 ug/ml. Different colors indicate ‘snapshots’ of different days during a constant 
doxycycline-induction: Day 0 (Green), Day 1 (Black), Day 3 (Blue), Day 5.5 (Red).  
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Figure 5.11: At fifth day of constant high level of doxycycline induction ([dox] = 6 ug/ml), a 
single-cell transcript distributions that are markedly different from the zeroth day (‘wild-
type’) distributions are reached. 
0 100 200 300 400 5000
5
10
15
20
25
Oct4 Transcript Counts
%
 o
f p
op
ul
at
io
n
[dox] = 6 ug/ml; Day 5
0 50 100 150 200 250 300 3500
5
10
15
20
Sox2 Transcript Counts
%
 o
f p
op
ul
at
io
n
[dox] = 6 ug/ml; Day 5
0 100 200 300 400 5000
2
4
6
8
10
12
14
16
18
Oct4 Transcript Counts
%
 o
f p
op
ul
at
io
n
wild-type
0 50 100 150 200 250 300 3500
2
4
6
8
10
12
14
Sox2 Transcript Counts
%
 o
f p
op
ul
at
io
n
wild-type
114
5.5. Future directions 
 We have presented our initial studies in which we perturbed the expression level of 
Nanog, one of three key transcription factors that plays an essential role in the pluripotency 
transcriptional network. Specifically, we demonstrated that the stem cell is able to detect an 
increase in Nanog expression beyond a certain level.  We showed that the cell responds by 
shutting down the total Nanog transcript level. We do not yet know by what mechanism the cell 
does this.  It may be a partial silencing of the Col1A locus where the pTET-Nanog has been 
integrated, or perhaps a more interesting mechanism such as RNAi that gets triggered for 
silencing both endogenous and exogenous Nanog transcript.  Certain miRNAs have been shown, 
in human embryonic stem cells, to target the coding region of key pluripotency genes. So this 
may be an intriguing possibility. Another future direction is to focus on a small, short-time scale 
perturbation of Nanog expression. This would be independent of the ‘threshold’ behavior we 
observed for the larger perturbation Nanog. A logical next step to take is building a careful, 
quantitative model that describes the shifts in the single-cell distributions that we observed as a 
result of the perturbation in Nanog. Overexpressing Oct4 and Sox2 using doxycycline is another 
logical follow-up study.  
 Our demonstration that some interesting features in Nanog, Sox2, and Oct4 transcripts 
within single stem cells exists sets up a stage for these future studies. 
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6. Experimental protocols 
 
6.1. Protocols used for yeast work (Chapter 3) 
 
1. Growing and storing plasmids: 
Plasmids need to be grown inside E. coli cells. Before a plasmid is to be transformed into a yeast 
cell, the host E.coli needs to proliferate. To do so, we grow the E.coli cells in LB media (Luria 
Broth) at 37 C.  Plasmids that have been extracted from E.coli cells can be stored in the 4C 
fridge. To grow up an appreciable number of E. coli cells, pick a single colony from a freshly 
streaked selective plate and inoculate a culture of 5 ml LB medium containing the selective 
antibiotic (usually ampicilin). Incubate for 12 hours at 37 C with vigorous shaking. 
2. Extracting a plasmid from E. coli: 
This protocol uses the Qiaprep spin miniprep kit. This method is not suitable for large (> 10 kbp) 
plasmids. 
Grow 5 mL of monoclonal E. coli cells for about 15 hours in a rotator in 37C.  
A. Harvest the bacterial cells by centrifugation at 8000 rpm for 3 min at room 
temperature. 
B. Resuspend the pelleted bacterial cells in 250 microliters Buffer P1 and 
transfer to a microcentrifuge tube. Make sure no bacterial clumps remain. 
Ensure that RNase A has been added to buffer P1. 
C. Add 250 microliters Buffer P2 and mix thoroughly by inverting the tube 4-6 
times. DO NOT Vortex. Do not allow reaction to proceed more than 5 min. 
D. Add 350 microliters Buffer N3 and mix immediately and thoroughly by 
inverting the tube 4-6 times. The solutin should become cloudy. 
E. Centrifuge for 10 min at 13000 rpm. 
F. Decant the supernatant into a QIAprep spin column by decanting or pipetting 
G. Centrifuge at 13000 rpm for 30 to 60 seconds. Discard flow through. 
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H. Wash the QIAprep spin column by adding 0.5 ml Buffer PB and centrifuging 
30-60 s. Discard flow through. 
I. Wash spin column by adding 0.75 ml Buffer PE and centrifuging for 30-60 s. 
J. Discard flow-through and centrifuge for additional 1 minute. This is 
important. 
K. Place the QIAprep column in a clean 1.5 ml microcentrifuge tube. To elute 
DNA, add 50 microliter Buffer EB or water to the center fo each QIA prep 
spin column, let stand for 1 min, and then centrifuge for 1 min. 
This completes the extraction of the plasmid from the E. Coli. 
 
3.  Linearizing plasmids (Digestion): 
 Before a plasmid DNA can be transformed into a yeast genome, it needs to be linearized. 
Digestion might also be necessary prior to ligation steps. The linearization is achieved by cutting 
the plasmid at the required site with a restriction enzyme. The following protocol is to be used, 
for a final volume of 20 ul: 
A. Use 10 microliters plasmid 
B. Add 2 microliters buffer (It is at 10X) - look on the wall chart to see which 
buffer is to be used with the enzyme being used. 
C. Add 2 microliters of 10X BSA (if needed). 
D. Add 1 microliter of the restriction enzyme (do not use more than 1 microliter 
per 20 microliter final volume). 
E. Add 5 microliters of H2O (make up to 20 ul total). 
F. Incubate the mixture at 37 C for at least 3 hours (sometimes even overnight 
depending on the enzyme). 
This completes the linearization of the plasmid. Now the plasmid needs to be checked 
(purification). 
 
4.  Gel purification: 
 An agarose gel is used to perform electrophoresis to verify and extract the linearized 
plasmid. 
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A. Prepare 60 ml of 1% agarose gel using UltraPure Agarose. Dissolve the 
agarose in TAE buffer, not H2O. 
B. Boil the agarose solution in a microwave. 
C. Prepare the Gel Slab using the appropriate wells. 
D. Add sybersafe - 6 microliters for 60 ml agarose solution. The cybersafe is at 
10000X concentration. 
E. Add load dye to the dna that is to be checked. typical volumes are 20 
microliters of DNA and the load dye is 6X so about 4 microliters of load dye 
to 20 microliters dna should be good. 
F. For the ladder, mix 19 TAE, 1 ladder and 4 load dye. The ladder is kept at -
20C and the dye is kept at 4C. 
G. Inject the dna and ladder and control into the gel wells and run for 40 minutes 
at 110 volts. 
H. Check the DNA using the UV lamp 
I. Excise the DNA fragment from the Agarose gel with a blade and place in an 
eppendorf tube. 
J. Add three volumes of buffer QG to 1 volume of gel (1mg=1ul) 
K. Incubate at 50 C for 10 min (or until gel is completely dissolved). To help 
dissolve, mix by vortexing every 2 to 3 min.  
L. Check that the color of the dissolved solution is yellow. If the color is orange 
or violet, add 10 ul of 3M sodium acetate, ph 5.0 , and mix 
M. Add 1 gel volume of isopropanol to sample and mix. 
N. Place a QIAquick spin column in a provided 2 ml collection tube. 
O. Apply the sample to the spin column and centrifuge for one minute (maximum 
volume is 800 ul). If more than 800 ul is needed, load and spin again. 
P. Discard flow through and place the spin column in the collection tube. 
Q. Add 0.75 ml of Buffer PE to the column and centrifuge for 1 min. 
R. Discard flow through and centrifuge for additional 1 min. 
S. Place column in a clean eppendorf tube. 
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T. Elute the dna by adding 50 ul of water to the centre of the membrane. LET IT 
STAND FOR 1 MIN. Centrifuge for 1 min to collect the dna. 
 
5.  DNA Ligation: 
 DNA ligation is the process used to splice dna pieces together. These pieces must be 
compatible which is assured if the ends being spliced were both cut by the same restriction 
enzyme. 
A. The total volume for the reaction is 20 microliters 
B. Mix in a tube: 
•  1 ul backbone (the plasmid to which the fragment is being ligated) 
• 2 ul buffer - T4 DNA ligase buffer 
• 1 ul enzyme - T4 DNA ligase 
• 5 ul of each DNA fragment 
• Make up the rest of volume with water up to 2o ul. 
• Also make a control tube with backbone only (no insert) 
C. Vortex well, spin down and leave on bench for 1 hour 
D. Transform the resulting plasmid into E.Coli. 
  
6. Transforming plasmids into E.Coli: 
 Once a plasmid is ready, it must be introduced into E. Coli cells for proliferation. 
Competent E.Coli cells are required for this purpose. This protocol is for transforming 20 ul 
plasmid into E.Coli cells so first make ready an eppendorf tube containing 20 ul plasmid. 
A. Thaw competent E. Coli cells on ice. 
B. Add 75 ul competent E. coli cells to the  plasmid DNA and pipette gently to 
mix.  
C. Incubate on ice for 30 minutes. 
D. Incubate for 50 seconds at 42 C. 
E. Put back in ice for 2 minutes. 
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F. Add 0.9 ml LB media. 
G. Incubate for 1 hour at 37 C on shaker. 
H. Spin down and decant till only 100 ul is left in the tube. 
I. Plate on an antibiotic plate. 
 
7. Freezing E.coli and S. cerevisiae: 
A. Take 1 ml cells from the bottom of the culture tube. Do not centrifuge. Put 
these cells in a freezing tube. 
B. Add 0.5 ml of 80% glycerol. 
C. Freeze in -80 C. 
 
8. PCR: 
 PCR is a technique that is used to multiply a certain desired segment of a DNA sample. 
In order to use PCR one must first design primers. The primers must be such that one of the 
primers has an end homologous to one of the DNA strands at one end and the other primer must 
have an end homologous to the other strand at the other end. The other end of the primer should 
be designed to have the desired restriction site. 
A. The primers come in solid form 
B. Spin down the primer 
C. Make 1mM stock solution of the primer. The number of moles present is 
written on the sheet that comes with the primer. 
D. Vortex and spin down 
E. Make a 5 uM solution of the primer by dilution. 
F. To maximise the probability of success, use four different conditions in which 
to do the PCR. They are outlined in the table below (to make 100 ul final 
volume; all volumes in the table are in uL): 
 1 2 3 4 
water 74.5 59.5 64.5 49.5 
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10mM dNTPs 3 3 3 3 
50mM MgSO4 2 2 2 2 
template DNA 0.5 0.5 0.5 0.5 
5uM forward 
primer 
4 4 4 4 
5uM reverse 
primer 
4 4 4 4 
10x PCR 
enhancer 
0 0 10 10 
DNA polymerase 
(e.g. PFX) 
2 2 2 2 
 
G. Perform PCR in a thermocycler, with the appropriate melting temperature. 
 
9. PCR Purification 
Once the PCR process is complete the DNA needs to be collected in water. The process is as 
follows: 
A. Add 5 volumes of Buffer PB to 1 volume of the PCR sample and mix. 
B. Apply to a QIAquick column and centrifuge for 1 min. Discard flow through. 
C. Add 0.75 ml Buffer PE to the QIAquick column and centrifuge for 1 min. 
D. Discard flow through and centrifuge for additional 1 min. 
E. Place the column in a clean tube. Elute dna by adding 50 ul water, letting 
stand for 1 min and then centrifuging for 1 min. 
 
10. Colony PCR 
 
 A.  15 uL Zymolyase in a PCR tube. 
 B.  Scrape off ~ 1/4 colony with a pipette tip, inoculate into zymolyase. 
 C.  Run the tube in PCR w/ a program “GEN”. (~30 minutes). 
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 D.  Do PCR on this product. 
 
 
 
6.2. Protocols used for stem cell work (Chapter 5) 
 
1. Recipe for embryonic stem cell growth media 
62.5 mL FBS (for final 12.5% FBS) (Fetal Bovine Serum, HyClone) 
5 mL L-glutamine  (Gibco) 
5 mL pen/strep (Gibco) 
5 mL non-essential amino acids (NEAA) (Gibco) 
4 uL Beta-Mercaptoethanol (BME) 
1 aliquot LIF (7x107 units)  
fill to 500 mL knockout DMEM (Gibco) 
 
2. Recipe for freezer media (for freezing down cell lines into vials) 
For 20 mL total volume: 
12 mL DMEM (Gibco) 
4 mL CCS  (Cosmic Calf Serum, HyClone) 
4 mL DMSO (Invitrogen) 
 
3. Recipe for trypsin 
For 200 mL total volume: 
20 mL 2.5% trypsin (Gibco) 
432 uL 0.5M EDTA 
fill to 200 mL with 1X PBS 
 
Cell culture protocols  
4. Feeding cells (for 15 cm plates. For 10cm plates, cut all volumes in half): 
 A. Put media in waterbath to warm ~ 10 minutes. 
 B. Flame pipet carefully and aspirate off old media. 
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 C. Add 20 mL warmed media to plates near edge (adding to middle of plate can   
  potentially life cells off the plate). 
 
5. Splitting cells (for 15 cm plates. For 10cm plates, cut all volumes in half): 
 A. Aspirate old media out of plates the same way as in feeding cells. 
 B. Wash cells with 10 mL of 1x PBS, then aspirate out PBS. 
 C. Add 2mL 1x trypsin, make sure plate is coated, then place in incubator for ~ 5  
  minutes. 
 D. Fill a conical tube half way with fresh media while you wait. 
 E. Tap gently on the sides of plates to make sure all cells are lifted by the trypsin.  
  Then flame a plugged Pasteru pipet, and gently pipet up and down the trypsinized  
  cells, making sure there are no patches of cells still stuck, and that all the cells are  
  individually suspended. 
 F. To deactivate the trypsin add the trypsinized cells directly into the conical tube with 
  media. 
 G. Rinse plate once with fresh media and collect remaining media and cells in the  
   conical tube. It is important here to not wash the cells over the plate, as they will re- 
  stick, and you will lose cells. 
 H. Spin conical tube with media and cells for 1000 rpm for 3 minutes. 
 I. Aspirate out media, then resuspend in desired volume of media for plating (e.g. 1mL 
  media per plate). 
 
6. Freezing cells  
 A. Trypsinize cells according to above procedure. 
 B. Make fresh freezer media every time you freeze cells. Depending on what cells you  
  are freezing, you my have to count the cells beforehand to determine appropriate  
  aliquots and volume of freezer media needed. 
 C. Label cryo tubes with. 
 D. Aliquot 0.75 mL cells, making sure to carefully resuspend every time, to assure  
      consistent suspension. 
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 E. As quickly as possible, aliquot 0.75 mL freezer media, cap then place tubes in a Mr. 
  Frosty filled with isopropanol, and place I nthe -80 freezer overnight. 
 F. Once frozen, place tubes in appropriate liquid nitrogen box. 
 
 
7. Single molecule RNA FISH protocols 
This material has been adapted from a similar protocol designed for yeast, which appeared 
in: 
H. Youk, A. Raj, and A. van Oudenaarden, Methods in Enzymology 470, pp429-446 (2010). 
 
 A brief overview of our method is as follows.  A set of short (between 17 to 22 bases 
long) oligonucleotide probes that bind to a desired target mRNA are designed and are coupled to 
a fluorophore (such that one oligonucleotide probe is bound to a single fluorophore) with desired 
spectral properties. After fixing the yeast cells, these probes are hybridized to the target mRNA 
molecule. This results in multiple (typically about 48) singly-labeled probes bound to a single 
mRNA molecule. In turn, the mRNA molecule can give off enough fluorescence to be detected 
as a diffraction-limited spot using a standard fluorescent microscope. Below we describe a step-
by-step procedure that was implemented for the RNA FISH in embryonic stem cells, presented 
in Chapter 5. 
(i) Designing oligonucleotides 
 The first step is the design of a collection of oligonucleotide probes that together are 
complimentary to a large part of the open read frame of the target mRNA (one can also utilize 
the untranslated regions of the mRNA if necessary).  Each probe is between 17 to 22 bases long 
and we have generally found that 30 or more such probes are sufficient to give a detectable 
signal.  We have also found that our signals are sometimes clearer when the GC content of each 
probe is close to 45%. We also leave a minimum of two bases as a spacer between two adjacent 
probes that cover the mRNA, although it is possible that one can relax this requirement without 
any adverse effects.  A program that facilitates the designing of probes meeting the constraints 
mentioned above is available freely at http://www.singlemoleculefish.com.  Sometimes it is not 
possible to design probes that meet all the constraints mentioned above, and these criteria should 
not be viewed as absolutes, but more as guidelines we try to adhere to when possible.  After 
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designing the probes, we order them from companies with parallel synthesis capabilities (we use 
BioSearch Technologies based in Novato, California, USA) with 3’-amine modifications.  Since 
the synthesis typically results in a much larger number of oligonucleotides than are necessary, 
one should have them synthesized on the smallest possible scale (we typically have them 
synthesized on the 10 nmole (delivered) scale).  The 3’-amine then serves as a reactive group for 
the succinomidyl-ester coupling of the fluorophore described next.  
(ii). Coupling fluorophores to oligonucleotides 
 The next step is the attachment of a fluorophore with desired spectral properties to the 
commercially synthesized oligonucleotides (we will describe which fluorophores we use in the 
later section entitled “Choice of fluorophore and appropriate filter sets”).  We do this by pooling 
the oligonucleotides and coupling them en masse, thus reducing the labor involved.  In all the 
steps we describe below, we use RNase free water (Ambion) to prepare our solutions and use 
filtered pipette tips to prevent aerosol contaminations.   
Procedure: 
1.  From the commercially synthesized set of oligonucleotides, each at a concentration of 100 
 µM in RNase free water (we find this is a practical starting concentration to work with), 
 pipette around 1 nmol/10 µL of each oligonucleotide probe into a single microcentrifuge tube 
 (i.e. if there are 48 probes, then 1 nmol of each of the 48 probe solutions should be combined 
 into a single tube with a final volume of 480 µL).   
2.   Add 0.11 volumes (vol./vol.) of 1 M sodium bicarbonate (prepared with RNase free water) to 
 this probe mixture, resulting in a final sodium bicarbonate concentration of 0.1 M.  If the 
 total volume of the mixture at this stage is less than 0.3 mL, add enough 0.1 M sodium 
 bicarbonate to bring the final volume of the mixture to 0.3 mL.  
3.   Dissolve roughly 0.2 mg of the desired fluorophore (functionalized with a succinimidyl ester 
 group) separately into a tube containing 50 µl of 0.1 M sodium bicarbonate.  If using TMR, 
 first dissolve the TMR in about 5 µL of dimethyl sulfoxide (DMSO) and then add 50 µL of 
 0.1 M sodium bicarbonate to it.  This is because TMR does not readily dissolve in aqueous 
 solutions. 
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4.   Add the dissolved fluorophore to the 0.3 mL of probe mixture, vortex, and cover this tube in 
 aluminum foil to prevent photobleaching from unwanted exposure to ambient light. Leave 
 the tube in the dark overnight.  
5.  Next day, precipitate the probes out of solution by adding 12% vol./vol. of sodium acetate at 
 pH 5.2 followed by 2.5 volumes of ethanol (95% or 100%).   
6.  Place the tube at -70C for at least one hour, then spin the sample down at 16,000 RPM for at 
 least 15 minutes at 4C.   
7.  A small colored pellet should have collected at the bottom of the tube at this stage. This 
 pellet contains both the coupled and uncoupled oligonucleotides.  The vast majority of the 
 uncoupled fluorophore, however, remains in the supernatant, and so aspirate as much of this 
 supernatant away as possible without disturbing the pellet (one should take care to aspirate 
 soon after removal from the centrifuge, since oligonucleotides have a tendency to redissolve 
 rapidly at room temperature. 
 Note: Many precipitation protocols now call for another washing step in 70% ethanol.  We 
 have found this step unnecessary. 
8.  The pellet is stable and can be stored in -20C for up to one year.  This concludes the coupling 
 step. 
Choice of fluorophore and appropriate filter sets: 
 In order to perform imaging of multiple different RNA species at the same time, one 
needs to select fluorophores with excitation and emission properties that can be distinguished by 
appropriately chosen bandpass filters; otherwise, the signal from one channel may potentially 
bleed into another channel.  We describe here the fluorophore and filter set combination that we 
use for our microscopy.  Other combinations are no doubt feasible as well. 
 The fluorophores we utilize are TMR (tetramethylrhodamine), Alexa 594 and Cy5.  TMR 
has proven to be exceptionally photostable in our hands, and its excitation maximum of 550 nm 
aligns nicely with the excitation maxima of mercury and metal-halide light sources.  Alexa 594 is 
also quite photostable, and while it’s spectral properties are similar to those of TMR (absorption 
127
at 594nm), we are able to distinguish its presence using appropriate filters.  The third fluorophore 
we use is Cy5, which is rather bright and is spectrally separated from the other two fluorophores 
(Cy5 absorbs at 650nm).  Cy5 does, however, suffer from photobleaching effects, thus requiring 
the use of a glucose oxidase oxygen scavenging system to make imaging feasible.  We have not 
tried any dyes that are further redshifted than Cy5.  However, we have experimented with Alexa 
488, which absorbs at a lower wavelength than TMR.  While we were sometimes able to detect 
signals, the higher cellular background at these lower wavelengths lead to weaker signals, so we 
generally avoid the use of fluorophores bluer than TMR. 
 The filters combinations we use are typical bandpass filter and dichroic sets mounted in 
cubes that the microscope can place in the fluorescence light path.  For TMR, we use a standard 
XF204 filter from Omega Optical.  For Alexa 594, we use a custom filter from Omega Optical 
with a 590DF10 excitation filter, a 610DRLP dichroic, and a 630DF30 emission filter.  For Cy5, 
we use the 41023 filter from Chroma, which is designed for Cy5.5.  It is likely that a filter more 
appropriate for Cy5 would work even better.  These filters do a good job of preventing any 
signals from one fluorophore from being detected in another channel (Raj et al. 2008).  
Sometimes a very bright Alexa 594 signal can bleed somewhat into the TMR channel (we 
estimate the bleed through to be about 10%) but practically this bleedthrough is impossible to 
detect owing to the low signal intensities of the mRNA spots.  
(iii). Purification of probes using HPLC: 
 We now describe a purification procedure for separating the coupled oligonucleotides 
from the uncoupled oligonucleotides.  We purify the coupled oligonucleotides using HPLC 
(High Performance Liquid Chromatography): the addition of the fluorophore makes the normally 
hydrophilic oligonucleotide significantly more hydrophobic, allowing for separation by 
chromatography.  The HPLC should be equipped with a dual wavelength detector for a 
simultaneous measurement of absorption by DNA (at 260 nm) and fluorophore (depends on the 
fluorophore: e.g. 555 nm for TMR and 594 nm for Alexa 594).  In our lab, we have used an 
Agilent 1090 equipped with Chemstation software and a C18 column suitable for oligonucleotide 
purification (218TP104).  The two buffers used for HPLC are: 0.1M triethylammonium acetate 
(“Buffer A”) and acetonitrile (“Buffer B”).   
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Procedure: 
1.  Before running the purification program on the HPLC, equilibrate the column by flowing 
 93% buffer A/7% Buffer B through for about 10 minutes; if the column is not equilibrated, 
 then the oligonucleotides will simply flow straight through without any separation.   
2.  Re-suspend the oligonucleotide pellet in an appropriate volume of water (we use 115 µl) and 
 then inject this into the HPLC inlet.   
3.  Run a HPLC program in which the percentage of buffer A varies from 7% to 30% over the 
 course of about 45 minutes with a flow rate of 1 mL per minute. During the execution of the 
 program, carefully monitor the two absorption curves, one for DNA (at 260 nm) and the 
 other for the coupled fluorophore (e.g. 555 nm for TMR and 594 nm for Alexa 594).  
 Generally speaking, one will observe two broad peaks over time.  The first peak, containing 
 the more hydrophilic material, consists of the uncoupled oligonucleotides and will only 
 exhibit absorption in the 260 nm channel (Fig. 6.1A).  This peak may appear relatively 
ragged  due to the presence of multiple oligonucleotides, each of which has a slightly different 
 retention time in the HPLC.  The second peak, often narrower than the first, will appear some 
 time after the first peak and contains the coupled oligonucleotides; thus, it will show 
 absorption in both the 260 nm and the fluorescent (e.g., 555 nm) channels (Fig. 6.1B).  The 
 duration of time between the first and second peaks varies depending on the hydrophobicity 
 of the fluorophore; we have found that oligonucleotides coupled to Cy5 have a long retention 
 time of almost 20 minutes after the first peak, whereas TMR and Alexa 594 result in shorter 
 retention shifts (Fig. 6.1B).   
4.  Collect the contents of this peak (in the flurophore absorption channel) manually into clean, 
 RNase free tubes.  It is important to collect all the solution that is coming out of the outlet, 
 starting from the beginning of the left shoulder of this second peak and stopping the 
 collection just at the tail-end of the right shoulder of this second peak (Fig. 6.1B), because 
the  different coupled oligonucleotides will have slightly different retention times; do not just 
 “collect the peak”.  This collection typically lasts around 3-7 minutes in our experience.  
 With the volumes we mentioned for our HPLC setup above, we typically collect between 5 to 
 14 mL in this step with 0.5 mL per tube.  The program we use then typically flows 70% 
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 Buffer B throught the column for about 10 minutes.  This step will “strip” the column of any 
 impurities that may have stuck to the column and is especially important if you plan to purify 
 additional probes.  Be sure, however, to allow sufficient time for the column to re-equilibrate 
 to 7% B/93% A before injecting another sample.   
5.  After collecting the solution of coupled probes, dry the collection in a speedvac rated for 
 acetonitrile until the liquid is fully evaporated (about 3 to 5 hours).  It is important to keep 
 light out of the Speedvac to avoid photobleaching of dyes, especially for highly photolabile 
 cyanine dyes such as Cy3 and especially Cy5.   
6.  Re-suspend the contents in a total of 50 to 100 µL of TE (10 mM Tris with HCl to adjust pH, 
 1 mM EDTA, Ambion) at pH 8.0.  This final suspension solution is now the “probe stock”. 
7. From the “probe stock”, create dilutions of 1:10, 1:20, 1:50, and 1:100 in TE to make 
 “working stocks”.  This dilution series is used to determine which concentration of probes 
 yields the best signals for RNA FISH.   
8.  Store these probes in dark at -20 C until sample is ready to be prepared. We found that the 
 probes can be stored for years in this way. 
(iv). Fixing embryonic stem cells 
 Having isolated the coupled probes, it is now time to fix the stem cells so that these 
probes can be hybridized to their target mRNAs in these cells.  
Procedure:  
1.  Add 5 mL of 37% formaldehyde (i.e. 100 % formalin) directly to the growth media 
 containing the cells and let it sit for 15 minutes at room temperature to fix the cells.  One 
 should take safety precautions when using the carcinogen, formaldehyde (i.e. use chemical 
 fume hood, gloves, and long-sleeved protective clothing).  
2.  After spin down and washing with 1x PBS, add 1 mL of 70% ethanol (diluted in RNase free 
 water) to the cells and leave them for an  hour or even overnight at 4 C.   
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 The stem cells have now been fixed and are ready for hybridization.  These cells can be stored in 
ethanol for up to a week after fixation and perhaps even longer. 
(v). Hybridizing probes to target mRNA 
 The hybridization step contains three key parameters that may be varied to optimize the 
FISH signal.  These are the temperature at which hybridization takes place, the concentration of 
formamide used in the hybridization and wash, and the concentration of the probe.  The first two 
parameters essentially set the stringency of the hybridization; i.e., the higher the temperature or 
the concentration of formamide, the lower the likelihood of nonspecific binding of the probes. 
Formamide is used in both DNA and RNA FISH for stabilizing single stranded, denatured DNA 
and for deionizing RNA. We usually elect to adjust the formamide concentration rather than 
temperature and thus perform all FISHs at 30 C.  Typcially, we have found that hybridization 
and wash buffers containing 10% formamide work quite nicely for most probes, yielding a fairly 
low background while also producing clear particulate signals.  However, when the GC content 
of the probes is relatively high (>55%), we have found that we sometimes have to employ 
formamide concentrations up to 20% or sometimes higher.  However, care must be taken in these 
instances, since the use of higher formamide concentrations can sometimes lead to a greatly 
diminished signal.  Generally, we try to obtain signals at a standard concentration of formamide, 
because this greatly facilitates the simultaneous detection of multiple mRNAs: if the 
hybridization conditions are the same, multiplex detection is simply a matter of mix and match. 
The concentration of probe used is also very important in obtaining clear, low 
background signals.  Typically, the optimal probe concentration must be found empirically, but 
we have found that concentrations can vary over roughly an order of magnitude and still produce 
satisfactory results.  We typically start by using a 1:1000, 1:2500 and 1:5000 dilution of the 
original stock into hybridization buffer.  One of these concentrations will usually yield good 
signals, but sometimes one must use drastically lower concentrations (100 fold lower) in order to 
obtain signals. 
(v). a. Preparation of hybridization and wash buffers 
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 The following procedure describes preparation of 10 mL of hybridization buffer with the 
desired formamide concentration.  Be sure to adjust the volumes appropriately if you’re 
preparing a different total volume of hybridization buffer. 
Procedure: 
1. Dissolve 1 g of high molecular weight dextran sulfate (>50,000) in approximately 5 mL of 
 nuclear free water.  Depending on the particular preparation of dextran sulfate used, the 
 powder may dissolve quite rapidly with a bit of vortexing or may require rocking for several 
 hours at room temperature.  In the end, the solution should be clear and fairly viscous, 
 although some preparations are far less viscous but still appear to work.   
2.   Add 10 mg of E. coli tRNA (Sigma, 83854), vortexing to dissolve.   
3.  Add 1mL of 20x SSC (RNase free, Ambion), 40 µL (to get 0.02% in 10 mL) of RNase free 
 BSA (stock is 50 mg/mL =  5% solution from Ambion, AM261), 100 µL of 200mM vanadyl-
 ribonucleoside complex (NEB S1402S), formamide to the desired concentration (10%-30%), 
 and then water to a final volume of 10mL. When using formamide, one must first warm the 
 solution to room temperature before opening to avoid oxidation; also, care must be taken 
 when using formamide (i.e., use in the hood, wear protection, etc.) because it is a suspected 
 carcinogen and teratogen and is readily absorbed through the skin. 
4.  Once the solution is thoroughly mixed, filter the buffers into small aliquots; this removes any 
 potential clumps that can yield a spotty background.  We simply filter the solution in 500 µL 
 aliquots using cartridge filters from Ambion.  
5.   Store the solution at -20C for later use; solution is typically good for several months to a 
 year. 
6.  Prepare the wash buffer by combining 5 mL of 20x SSC (Ambion), 5 mL of formamide (to 
 final concentration of 10% vol./vol.; this is adjusted if the hybridization buffer has a different 
 formamide concentration), and 40 mL of RNase free water (Ambion) into one solution. 
(v). b. Hybridizing probes to stem cells in solution 
Procedure: 
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1. Warm the hybridization solution to room temperature before opening its cap to prevent 
 oxidation of the formamide.   
2.  Add 1-3 µL of desired concentration of probes to 100 µL of the hybridization buffer.  To 
 determine what the desired concentration of probes is, we initially perform hybridizations 
 with four dilutions of probes: 1:10, 1:20, 1:50 and 1:100 (mentioned in “Purification of 
 probes using HPLC” section), and see which dilution gives the clearest signal.   
3.  Centrifuge the fixed sample and aspirate away the ethanol, then resuspend the fixed cells in a 
 1 mL wash buffer containing the same formamide concentration as the hybridization buffer.   
4.  Let the resuspension stand for about 2-5 minutes at room temperature. 
5.  Centrifuge the sample and aspirate the wash buffer. Then add the hybridization solution.   
6.  Incubate the sample overnight in the dark at 30 C. 
7.  Next morning, add 1 mL of wash buffer to this sample, vortex, centrifuge, then aspirate away 
 the supernatant.   
8.  Resuspend in 1 mL of wash buffer, then incubate in 30 C for 30 minutes.  
9.  Repeat the wash in another 1 mL of wash buffer for another 30 minutes at 30 C, this time 
 adding 1 µl of 5 mg/mL DAPI for a nuclear stain.   
10. A : If using photostable fluorophores such as TMR or Alexa 594: then there is no need to add 
 the GLOX solution.  Just resuspend the sample in an appropriate volume (larger than 0.1 mL) 
 of 2x SSC and proceed to imaging.   
10 B: If using a highly photolabile fluorophore such as Cy5: resuspend the fixed cells in the 
 GLOX buffer (used as an oxygen-scavenger that removes oxygen from the medium to 
 prevent light-initiated fluorophore destroying-reactions; see section 2.5. C) without the 
 enzymes and incubate it for about 2 minutes for equilibration (see next section for details).  
 Then centrifuge, aspirate away the buffer and resuspend the cells in a 100 µL of GLOX 
 buffer with the enzymes (glucose oxidase and catalase).  These cells are now ready to be 
 imaged.   
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 We found that our samples (either with or without the anit-bleach solution) can be kept at 
4C for a day’s worth of imaging.  Keeping the samples at 4C prevents the probe-target hybrids 
from dissociating and thus degrading the signals. 
(v). c. Preparation of anti-bleach solution and enzymes (“GLOX solution”) 
 During imaging, we typically take several vertical stacks (“z-stacks”) of images through a 
cell in a field of view, causing a hybridized fluorophore in a fixed cell to be excited by intense 
light several times.  More importantly, when more than one type of fluorophore is used for 
imaging two or three species of mRNA, such z-stacks must be repeated to excite each of the 
different fluorophores, leading to even more exposure of the fluorophores.  In our experience, 
only TMR and Alexa 594 could withstand such repeated excitations, whereas Cy5 signal would 
rapidly degrade due to its especially high rate of photobleaching.  To decrease the photolability 
of Cy5, we used an oxygen-scavenging system consisting of catalase, glucose oxidase, and 
glucose (GLOX solution) that is slightly modified from that used by (Yildiz et al. 2003).  This 
GLOX solution acts as an oxygen-scavenger that removes oxygen from the medium.  Since the 
light-initiated reactions that destroy fluorophores require oxygen, the GLOX buffer thus 
prohibits these reactions from taking place.  Indeed, we found that Cy5 was able to withstand 
nearly 10 times more exposure with the GLOX solution than without it.  The following is a 
procedure for preparing the GLOX solution. 
Procedure: 
1.  Mix together 0.85 mL of RNase free water with 100 µL of 20x SSC, 40 µL of 10% glucose, 
 and 5 µL of 2 M Tris CL (pH 8.0).  This is the GLOX buffer (without glucose oxidase and 
 catalase). 
2.  Vortex the mixture, and then aliquot 100 µL of it into another tube.   
3. To this 100 µL aliquot of GLOX buffer (GLucose-OXygen scavenging solution without 
 enzymes), add 1 µL of glucose oxidase (from 3.7mg/mL stock, dissolved in 50mM sodium 
 acetate, pH 5.2, Sigma) and 1 µL of catalase (Sigma).  Before pipetting the catalase, vortex it 
 a bit, since the catalase is kept in suspension (also, care should be taken when handling the 
 catalase, since it has a tendency to get contaminated).  This 100 µL will be referred to as 
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 “GLOX solution with enzymes”. The GLOX solution without the enzyme will later be used 
 as an equilibration buffer. 
(v). d. Imaging Samples Using Fluorescent Microscope 
 The fixed cells with probes properly hybridized are now ready for imaging.  Our 
microscopy system is relatively standard: we use a Nikon TE2000 inverted widefield 
epifluorescence microscope.  It is important to use a fairly bright light source.  For instance, a 
standard mercury lamp will suffice, although the newer metal-halide light sources (e.g., Lumen 
200 from Prior) tend to produce a more intense and uniform illumination.  Another important 
factor is the camera.  It is important to use a cooled CCD camera that is optimized for low-light 
imaging rather than acquisition speed; we use a Pixis camera from Roper.  Also, the camera 
should have a pixel size of 13 µm or less.  We should point out that the signals from the newer 
EMCCD cameras are no better than these more standard (and cheaper) cooled CCD cameras.   
We typically use a 100x DIC objective.  If one is interested in imaging with Cy5, one must be 
sure that the objective has sufficient light transmission at those longer wavelengths; this can 
sometimes require an IR coating.  When mounting the cells, it is important to make sure that one 
uses #1 coverglass (18 x 18 mm, 1 ounce) and that the yeast are directly on the coverglass: do 
not adhere the yeast to the slide and then cover with coverglass.  One can enhance the adherence 
of the yeast to the coverglass by coating the coverglass with poly-L-lysine (put fresh 1 mg/mL 
poly-L-lysine solution on the coverglass for 20 minutes, then suction off) or concanavalin A.  It 
is also important to use #1 coverglass: we have found that even though most objectives are 
corrected for #1.5 coverglass, the mRNA spots are usually fuzzier and less distinct when imaged 
through #1.5 coverglass. 
There are two somewhat standard procedures often employed during fluorescence 
microscopy that we have found interferes with our single mRNA signals.  One of these is the use 
of commercial anti-fade mounting solutions, which tend to introduce a large background while 
also decreasing the fluorescent signals from target mRNAs.  We recommend instead using the 
custom made GLOX solution or 2x SSC for imaging, being careful not to let the sample dry out.  
We also discourage using the standard practice of using a nail polish to seal the sample, as it 
introduces a background autofluorescence in the red channels that interferes with fluorescence 
from mRNA. 
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(vi). Image processing: Detecting diffraction limited mRNA spot 
 We have devised an algorithm that automates some fraction of the work involved in 
analyzing images obtained from the samples (Raj et al. 2008).  The first step in our algorithm is 
applying a three-dimensional linear filter that is approximately a Gaussian convolved with a 
Laplacian to remove the non-uniform background while enhancing the signals from individual 
mRNA particles, thus enhancing the signal-to-noise ratio (SNR) (Fig. 6.2B).  The full width at 
half maximum of this Gaussian corresponds to the optimal bandwidth of our filter, and depends 
on the size of the observed particle.  This width is a fit parameter that we empirically adjust to 
maximize the SNR.  However, even after filtering the images, they will contain some noise that 
requires thresholding to remove.  In order to make a principled choice of threshold, we sweep 
over a range of possible values of the threshold, and plot the number of mRNAs detected at each 
value (Fig. 6.2C).  Here, a single mRNA is defined as a collection of localized pixels (in the 
series of z-stacks) that form a connected component (Fig. 6.2D).  We then typically find a 
plateau in this plot of the number of mRNAs counted as a function of the value of the threshold 
(i.e. increasing the threshold does not change the number of mRNAs counted) as seen in Fig. 
6.2C.  This implies that the signals from mRNAs are well separated from the background noise 
rather than a smooth “blending” in of the mRNA signals with the background noise.  Indeed, the 
value of threshold chosen in this plateau range yielded mRNA counts nearly equal to the mRNA 
counts we obtained through an independent method in which we count by eye without the aid of 
automation.  The software used for this purpose is available for download on Nature method’s 
supplementary information site for  (Raj et al. 2008).  One can also make measurements based 
on mRNA spot intensity, although we feel that great care must be taken in these situations.  One 
issue is that the intensity depends on how precisely focused the spot is, although this can be 
ameliorated by taking a large number of closely spaced fluorescent stacks.  Another problem 
with computing total or mean intensity is that the boundary of the mRNA is hard to define, and 
the ultimate intensity measurement will depend heavily on this somewhat arbitrary choice.  One 
way to skirt the issue is to use the maximum intensity within a given spot, since this is 
independent of the size of the spot. 
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 Figure 6.1: Chromatographs obtained during the HPLC purification of oligonucleotides 
coupled to the fluorophore (Alexa 594) from uncoupled oligonucleotides. (A) Absorption (at 
260 nm, for DNA) curve as a function of time monitored during purification of probes coupled to 
Alexa 594 using HPLC. The first peak that appears between 20 and 30 minutes in this channel 
correspond to oligonucleotide probes that do not have Alexa 594 coupled to them.  Eluate is not 
collected for the duration of this peak. (B) Absorption (at 594 nm, for Alexa 594) curve as a 
function of time.  Both absorption curves (A) and (B) are obtained simultaneously for the 
duration of the HPLC run. Only one distinct peak appears in this channel, representing 
absorption by probes with Alexa 594 successfully coupled to them. This peak coincides with the 
second peak in the 260 nm channel shown in (A).  Eluate is collected for the entire duration of 
this peak in the 594 nm channel. (Reprinted from H. Youk, A. Raj, and A. van Oudenaarden. 
Methods in Enzymology 470, 429-446 (2010)). 
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 Figure 6.2: Example of mRNA spot detection algorithm applied to raw images of FKBP5 
mRNA particles in A549 cells induced with dexamethasone. (A) Raw image data showing 
FKBP5 mRNA particles. (B) Upon applying a three-dimensional linear filter that is 
approximately a Gaussian convolved with a Laplacian to remove the non-uniform background 
while enhancing the signals from individual mRNA particles on the raw image shown in (A) the 
signal-to-noise ratio (SNR) is increased. (C) The number of spots counted as a function of the 
threshold value of the background after the application of the linear filter shows an existence of a 
plateau.  This indicates a clear distinction between background fluorescence and actual mRNA 
spots. (D) Using the value of threshold shown as the grey line in (C), the raw image (A) has been 
transformed to an image in which each distinct computationally identified spot has been assigned 
a random color to facilitate visualization. (Reprinted from A. Raj, P. van den Bogaard, S. Rifkin, 
A. van Oudenaarden, and S. Tyagi. Nature methods 5, 877-879 (2008)). 
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